{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T19:06:47Z","timestamp":1791745607382,"version":"4.3.4"},"reference-count":260,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["NO. 82174203"],"award-info":[{"award-number":["NO. 82174203"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Xiyuan Hospital Talent Fund of China Academy of Chinese Medical Sciences","award":["NO. XYZXRC02-01"],"award-info":[{"award-number":["NO. XYZXRC02-01"]}]},{"name":"the Special Fund for Cultivating Outstanding Young Scientific and Technological Talents of the China Academy of Chinese Medical Sciences","award":["NO. CI2023D005"],"award-info":[{"award-number":["NO. CI2023D005"]}]},{"name":"Beijing Natural Science Foundation","award":["NO. 7262215"],"award-info":[{"award-number":["NO. 7262215"]}]},{"name":"the Capital Health Development Research Special Project","award":["NO. 2024-2-4174"],"award-info":[{"award-number":["NO. 2024-2-4174"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04481-4","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T06:55:42Z","timestamp":1778482542000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic strategies for ischemic heart disease with natural product-based nanomedicines"],"prefix":"10.1186","volume":"24","author":[{"given":"Pei-rong","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-ming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long-xin","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-wei","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-geng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-zi","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"issue":"10440","key":"4481_CR1","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/S0140-6736(24)00685-8","volume":"403","author":"GBD 2021 Forecasting Collaborators","year":"2024","unstructured":"GBD 2021 Forecasting Collaborators. Burden of disease scenarios for 204 countries and territories, 2022\u20132050: a forecasting analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2204\u201356. https:\/\/doi.org\/10.1016\/S0140-6736(24)00685-8.","journal-title":"Lancet"},{"issue":"4","key":"4481_CR2","first-page":"2141","volume":"105","author":"C Monaco","year":"2025","unstructured":"Monaco C, McNamara CA, Sl\u00fctter B, et al. Immunotherapy for atherosclerosis. Physiol Rev. 2025;105(4):2141\u2013230. 10.1152. \/physrev.00016.2024.","journal-title":"Physiol Rev"},{"issue":"1","key":"4481_CR3","doi-asserted-by":"publisher","first-page":"e184134","DOI":"10.1172\/JCI184134","volume":"135","author":"Y Mastoor","year":"2025","unstructured":"Mastoor Y, Murphy E, Roman B. Mechanisms of postischemic cardiac death and protection following myocardial injury. J Clin Investig. 2025;135(1):e184134. https:\/\/doi.org\/10.1172\/JCI184134.","journal-title":"J Clin Investig"},{"issue":"5","key":"4481_CR4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1136\/heartjnl-2015-308037","volume":"102","author":"N Briceno","year":"2016","unstructured":"Briceno N, Schuster A, Lumley M, et al. Ischaemic cardiomyopathy: pathophysiology, assessment and the role of revascularisation. Heart. 2016;102(5):397\u2013406. 10.1136. \/heartjnl-2015-308037.","journal-title":"Heart"},{"key":"4481_CR5","doi-asserted-by":"publisher","first-page":"102629","DOI":"10.1016\/j.arr.2024.102629","volume":"104","author":"L Zhu","year":"2025","unstructured":"Zhu L, Liu Y, Wang K, et al. Regulated cell death in acute myocardial infarction: Molecular mechanisms and therapeutic implications. Ageing Res Rev. 2025;104:102629. https:\/\/doi.org\/10.1016\/j.arr.2024.102629.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"4481_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10741-019-09831-z","volume":"25","author":"BR Pagliaro","year":"2020","unstructured":"Pagliaro BR, Cannata F, Stefanini GG, et al. Myocardial ischemia and coronary disease in heart failure. Heart Fail Rev. 2020;25(1):53\u201365. https:\/\/doi.org\/10.1007\/s10741-019-09831-z.","journal-title":"Heart Fail Rev"},{"key":"4481_CR7","doi-asserted-by":"publisher","unstructured":"Diseases and Injuries Collaborators 2021 GBD. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet (London England). 2024;403(10440):2133\u201361. https:\/\/doi.org\/10.1016\/S0140-6736(24)00757-8. https:\/\/doi.org\/10.1016\/S0140-6736(24)00757-8.","DOI":"10.1016\/S0140-6736(24)00757-8"},{"issue":"31","key":"4481_CR8","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1093\/eurheartj\/ehaf323","volume":"46","author":"M Darvish","year":"2025","unstructured":"Darvish M, Shakoor A, Feyz L, et al. Heart failure: assessment of the global economic burden. Eur Heart J. 2025;46(31):3069\u201378. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf323.","journal-title":"Eur Heart J"},{"issue":"4","key":"4481_CR9","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.devcel.2022.01.012","volume":"57","author":"JC Garbern","year":"2022","unstructured":"Garbern JC, Lee RT. Heart regeneration: 20 years of progress and renewed optimism. Dev Cell. 2022;57(4):424\u201339. https:\/\/doi.org\/10.1016\/j.devcel.2022.01.012.","journal-title":"Dev Cell"},{"key":"4481_CR10","doi-asserted-by":"publisher","first-page":"123214","DOI":"10.1016\/j.biomaterials.2025.123214","volume":"319","author":"N Zhang","year":"2025","unstructured":"Zhang N, Gao M, Hu X, et al. Biomimetic peroxisome targets myocardial injury and promotes heart repair and regeneration. Biomaterials. 2025;319:123214. https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123214.","journal-title":"Biomaterials"},{"issue":"1","key":"4481_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12951-025-03092-9","volume":"23","author":"H Liu","year":"2025","unstructured":"Liu H, Jin X, Liu S. et, al. Recent advances in self-targeting natural product-based nanomedicines. J Nanobiotechnol. 2025;23(1):31. https:\/\/doi.org\/10.1186\/s12951-025-03092-9.","journal-title":"J Nanobiotechnol"},{"issue":"35","key":"4481_CR12","doi-asserted-by":"publisher","first-page":"e2403388","DOI":"10.1002\/advs.202403388","volume":"11","author":"X Guo","year":"2024","unstructured":"Guo X, Luo W, Wu L, et al. Natural Products from Herbal Medicine Self-Assemble into Advanced Bioactive Materials. Adv Sci (Weinheim Baden-Wurttemberg Germany). 2024;11(35):e2403388. https:\/\/doi.org\/10.1002\/advs.202403388. https:\/\/doi.org\/10.1002\/advs.202403388.","journal-title":"Adv Sci (Weinheim Baden-Wurttemberg Germany)"},{"key":"4481_CR13","doi-asserted-by":"publisher","first-page":"153419","DOI":"10.1016\/j.phymed.2020.153419","volume":"81","author":"J Lyu","year":"2021","unstructured":"Lyu J, Xue M, Li J, et al. Clinical effectiveness and safety of salvia miltiorrhiza depside salt combined with aspirin in patients with stable angina pectoris: A multicenter, pragmatic, randomized controlled trial. Phytomedicine: Int J phytotherapy phytopharmacology. 2021;81:153419. https:\/\/doi.org\/10.1016\/j.phymed.2020.153419.","journal-title":"Phytomedicine: Int J phytotherapy phytopharmacology"},{"key":"4481_CR14","doi-asserted-by":"publisher","first-page":"155206","DOI":"10.1016\/j.phymed.2023.155206","volume":"123","author":"M Huang","year":"2024","unstructured":"Huang M, Du H, Lai J, et al. Clinical efficacy of Kuanxiong aerosol for patients with prehospital chest pain: A randomized controlled trial. Phytomedicine: Int J phytotherapy phytopharmacology. 2024;123:155206. https:\/\/doi.org\/10.1016\/j.phymed.2023.155206.","journal-title":"Phytomedicine: Int J phytotherapy phytopharmacology"},{"issue":"12","key":"4481_CR15","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.jacc.2013.05.035","volume":"62","author":"X Li","year":"2013","unstructured":"Li X, Zhang J, Huang J, Efficacy and Safety of Qili Qiangxin Capsules for Chronic Heart Failure Study Group, et al. A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure. J Am Coll Cardiol. 2013;62(12):1065\u201372. https:\/\/doi.org\/10.1016\/j.jacc.2013.05.035.","journal-title":"J Am Coll Cardiol"},{"key":"4481_CR16","doi-asserted-by":"publisher","first-page":"156133","DOI":"10.1016\/j.phymed.2024.156133","volume":"135","author":"Y Wang","year":"2024","unstructured":"Wang Y, Wang X, Wang J, et al. A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the effect of Tongmai Yangxin pill on ventricular remodeling in acute anterior STEMI patients after primary PCI. Phytomedicine: Int J phytotherapy phytopharmacology. 2024;135:156133. https:\/\/doi.org\/10.1016\/j.phymed.2024.156133.","journal-title":"Phytomedicine: Int J phytotherapy phytopharmacology"},{"issue":"16","key":"4481_CR17","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1039\/d2tb00225f","volume":"10","author":"D Wei","year":"2022","unstructured":"Wei D, Yang H, Zhang Y, et al. Nano-traditional Chinese medicine: a promising strategy and its recent advances. J Mater Chem. 2022;10(16):2973\u201394. https:\/\/doi.org\/10.1039\/d2tb00225f.","journal-title":"J Mater Chem"},{"key":"4481_CR18","doi-asserted-by":"publisher","unstructured":"Gregoriadis G, Ryman BE. Liposomes as carriers of enzymes or drugs: a new approach to the treatment of storage diseases. Biochem J. 1971 October 1; 124 (5): 58P. https:\/\/doi.org\/10.1042\/bj1240058P. https:\/\/doi.org\/10.1042\/bj1240058P.","DOI":"10.1042\/bj1240058P"},{"key":"4481_CR19","doi-asserted-by":"publisher","first-page":"101583","DOI":"10.1016\/j.mtbio.2025.101583","volume":"31","author":"H Cheng","year":"2025","unstructured":"Cheng H, Liao J, Ma Y, et al. Advances in targeted therapy for tumor with nanocarriers: A review. Mater Today Bio. 2025;31:101583. https:\/\/doi.org\/10.1016\/j.mtbio.2025.101583.","journal-title":"Mater Today Bio"},{"key":"4481_CR20","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.2147\/IJN.S295508","volume":"16","author":"M Hesari","year":"2021","unstructured":"Hesari M, Mohammadi P, Khademi F, et al. Current Advances in the Use of Nanophytomedicine Therapies for Human Cardiovascular Diseases. Int J Nanomed. 2021;16:3293\u2013315. https:\/\/doi.org\/10.2147\/IJN.S295508. doi: 10.2147\/IJN.S295508.","journal-title":"Int J Nanomed"},{"issue":"22","key":"4481_CR21","doi-asserted-by":"publisher","first-page":"11031","DOI":"10.3390\/app112211031","volume":"11","author":"RK Sindhu","year":"2021","unstructured":"Sindhu RK, Goyal A, Alg\u0131n Yapar E, et al. Bioactive Compounds and Nanodelivery Perspectives for Treatment of Cardiovascular Diseases. Appl Sci. 2021;11(22):11031. https:\/\/doi.org\/10.3390\/app112211031.","journal-title":"Appl Sci"},{"key":"4481_CR22","doi-asserted-by":"publisher","first-page":"1529478","DOI":"10.3389\/fphar.2025.1529478","volume":"16","author":"W Shi","year":"2025","unstructured":"Shi W, Xu Y, Wei J, et al. Plant-derived secondary metabolites and nanotechnology: innovative strategies and emerging challenges in myocardial ischemia-reperfusion injury therapy. Front Pharmacol. 2025;16:1529478. https:\/\/doi.org\/10.3389\/fphar.2025.1529478.","journal-title":"Front Pharmacol"},{"key":"4481_CR23","doi-asserted-by":"publisher","first-page":"1511331","DOI":"10.3389\/fbioe.2024.1511331","volume":"12","author":"M Lv","year":"2025","unstructured":"Lv M, Sun Q, Yu Y, et al. Nanocurcumin in myocardial infarction therapy: emerging trends and future directions. Front Bioeng Biotechnol. 2025;12:1511331. https:\/\/doi.org\/10.3389\/fbioe.2024.1511331.","journal-title":"Front Bioeng Biotechnol"},{"issue":"24","key":"4481_CR24","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1016\/j.jacc.2017.04.041","volume":"69","author":"P Hao","year":"2017","unstructured":"Hao P, Jiang F, Cheng J, et al. Traditional Chinese Medicine for Cardiovascular Disease: Evidence and Potential Mechanisms. J Am Coll Cardiol. 2017;69(24):2952\u201366. https:\/\/doi.org\/10.1016\/j.jacc.2017.04.041.","journal-title":"J Am Coll Cardiol"},{"key":"4481_CR25","doi-asserted-by":"publisher","first-page":"118506","DOI":"10.1016\/j.jep.2024.118506","volume":"334","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, Li M, Zhang Z, et al. Overview of Panax ginseng and its active ingredients protective mechanism on cardiovascular diseases. J Ethnopharmacol. 2024;334:118506. https:\/\/doi.org\/10.1016\/j.jep.2024.118506.","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"4481_CR26","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1142\/S0192415X07005053","volume":"35","author":"CZ Wang","year":"2007","unstructured":"Wang CZ, Mehendale SR, Yuan CS. Commonly used antioxidant botanicals: active constituents and their potential role in cardiovascular illness. Am J Chin Med. 2007;35(4):543\u201358. https:\/\/doi.org\/10.1142\/S0192415X07005053.","journal-title":"Am J Chin Med"},{"key":"4481_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.phymed.2018.04.044","volume":"47","author":"L Duan","year":"2018","unstructured":"Duan L, Xiong X, Hu J, et al. Efficacy and safety of oral Panax notoginseng saponins for unstable angina patients: A meta-analysis and systematic review. Phytomedicine: Int J phytotherapy phytopharmacology. 2018;47:23\u201333. https:\/\/doi.org\/10.1016\/j.phymed.2018.04.044.","journal-title":"Phytomedicine: Int J phytotherapy phytopharmacology"},{"issue":"11","key":"4481_CR28","doi-asserted-by":"publisher","first-page":"5793","DOI":"10.1007\/s11010-025-05351-7","volume":"480","author":"P Ahmadi","year":"2025","unstructured":"Ahmadi P, Akbarzadeh S, Alizadeh M, et al. Resveratrol improves lipid profile and recovers heart function in postoperative CABG patients. Mol Cell Biochem. 2025;480(11):5793\u2013803. https:\/\/doi.org\/10.1007\/s11010-025-05351-7.","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"4481_CR29","doi-asserted-by":"publisher","first-page":"746","DOI":"10.3390\/jcm9030746","volume":"9","author":"B Salehi","year":"2020","unstructured":"Salehi B, Del Prado-Audelo ML, Cort\u00e9s H, et al. Therapeutic Applications of Curcumin Nanomedicine Formulations in Cardiovascular Diseases. J Clin Med. 2020;9(3):746. https:\/\/doi.org\/10.3390\/jcm9030746.","journal-title":"J Clin Med"},{"key":"4481_CR30","doi-asserted-by":"publisher","first-page":"104505","DOI":"10.1016\/j.phrs.2019.104505","volume":"150","author":"A Hadi","year":"2019","unstructured":"Hadi A, Pourmasoumi M, Ghaedi E, Sahebkar A. The effect of Curcumin\/Turmeric on blood pressure modulation: A systematic review and meta-analysis. Pharmacol Res. 2019;150:104505. https:\/\/doi.org\/10.1016\/j.phrs.2019.104505.","journal-title":"Pharmacol Res"},{"issue":"8","key":"4481_CR31","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1093\/nutrit\/nuaf012","volume":"83","author":"C Unhapipatpong","year":"2025","unstructured":"Unhapipatpong C, Julanon N, Shantavasinkul PC, et al. An Umbrella Review of Systematic Reviews and Meta-analyses of Randomized Controlled Trials Investigating the Effect of Curcumin Supplementation on Lipid Profiles. Nutr Rev. 2025;83(8):1520\u201336. https:\/\/doi.org\/10.1093\/nutrit\/nuaf012.","journal-title":"Nutr Rev"},{"issue":"5","key":"4481_CR32","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.jacc.2020.11.056","volume":"77","author":"AFG Cicero","year":"2021","unstructured":"Cicero AFG, Fogacci F, Zambon A. Red Yeast Rice for Hypercholesterolemia: JACC Focus Seminar. J Am Coll Cardiol. 2021;77(5):620\u20138. https:\/\/doi.org\/10.1016\/j.jacc.2020.11.056.","journal-title":"J Am Coll Cardiol"},{"key":"4481_CR33","doi-asserted-by":"publisher","first-page":"829416","DOI":"10.3389\/fphar.2022.829416","volume":"13","author":"L Duan","year":"2022","unstructured":"Duan L, Liu Y, Li J, et al. Panax notoginseng Saponins Alleviate Coronary Artery Disease Through Hypermethylation of the miR-194-MAPK Pathway. Front Pharmacol. 2022;13:829416. https:\/\/doi.org\/10.3389\/fphar.2022.829416.","journal-title":"Front Pharmacol"},{"issue":"15","key":"4481_CR34","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.3390\/nu16152441","volume":"16","author":"M Yaikwawong","year":"2024","unstructured":"Yaikwawong M, Jansarikit L, Jirawatnotai S, et al. The Effect of Curcumin on Reducing Atherogenic Risks in Obese Patients with Type 2 Diabetes: A Randomized Controlled Trial. Nutrients. 2024;16(15):2441. https:\/\/doi.org\/10.3390\/nu16152441.","journal-title":"Nutrients"},{"issue":"1","key":"4481_CR35","doi-asserted-by":"publisher","first-page":"28358","DOI":"10.1038\/s41598-025-09783-5","volume":"15","author":"OM El-Rakabawy","year":"2025","unstructured":"El-Rakabawy OM, Elkholy AA, Mahfouz AA, et al. Curcumin supplementation improves the clinical outcomes of patients with diabetes and atherosclerotic cardiovascular risk. Sci Rep. 2025;15(1):28358. https:\/\/doi.org\/10.1038\/s41598-025-09783-5.","journal-title":"Sci Rep"},{"issue":"2","key":"4481_CR36","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/ptr.3250","volume":"25","author":"CM Ahn","year":"2011","unstructured":"Ahn CM, Hong SJ, Choi SC, et al. Red ginseng extract improves coronary flow reserve and increases absolute numbers of various circulating angiogenic cells in patients with first ST-segment elevation acute myocardial infarction. Phytother Res. 2011;25(2):239\u201349. https:\/\/doi.org\/10.1002\/ptr.3250.","journal-title":"Phytother Res"},{"key":"4481_CR37","doi-asserted-by":"publisher","first-page":"104883","DOI":"10.1016\/j.phrs.2020.104883","volume":"158","author":"M Guo","year":"2020","unstructured":"Guo M, Wang P, Du J, et al. Xinyue Capsule in patients with stable coronary artery disease after percutaneous coronary intervention: a multicenter, randomized, placebo-controlled trial. Pharmacol Res. 2020;158:104883. https:\/\/doi.org\/10.1016\/j.phrs.2020.104883.","journal-title":"Pharmacol Res"},{"key":"4481_CR38","doi-asserted-by":"publisher","first-page":"1516059","DOI":"10.3389\/fphar.2025.1516059","volume":"16","author":"H Fan","year":"2025","unstructured":"Fan H, Yang J, Wang H, et al. Efficacy and safety of puerarin injection as an adjunctive therapy for chronic heart failure: a systematic review and meta-analysis. Front Pharmacol. 2025;16:1516059. https:\/\/doi.org\/10.3389\/fphar.2025.1516059.","journal-title":"Front Pharmacol"},{"key":"4481_CR39","doi-asserted-by":"publisher","first-page":"934598","DOI":"10.3389\/fcvm.2022.934598","volume":"9","author":"Z Li","year":"2022","unstructured":"Li Z, Fan Y, Huang C, et al. Efficacy and safety of Puerarin injection on acute heart failure: A systematic review and meta-analysis. Front Cardiovasc Med. 2022;9:934598. https:\/\/doi.org\/10.3389\/fcvm.2022.934598.","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"4481_CR40","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1002\/ptr.6955","volume":"35","author":"F Dehghani","year":"2021","unstructured":"Dehghani F, Sezavar Seyedi Jandaghi SH, Janani L, et al. Effects of quercetin supplementation on inflammatory factors and quality of life in post-myocardial infarction patients: A double blind, placebo-controlled, randomized clinical trial. Phytother Res. 2021;35(4):2085\u201398. https:\/\/doi.org\/10.1002\/ptr.6955.","journal-title":"Phytother Res"},{"issue":"7","key":"4481_CR41","doi-asserted-by":"publisher","first-page":"e002713","DOI":"10.1161\/JAHA.115.002713","volume":"5","author":"MC Serban","year":"2016","unstructured":"Serban MC, Sahebkar A, Zanchetti A, et al. Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group. Effects of Quercetin on Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Am Heart Association. 2016;5(7):e002713. https:\/\/doi.org\/10.1161\/JAHA.115.002713.","journal-title":"J Am Heart Association"},{"issue":"8","key":"4481_CR42","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1093\/nutrit\/nuz071","volume":"78","author":"H Huang","year":"2020","unstructured":"Huang H, Liao D, Dong Y, et al. Effect of quercetin supplementation on plasma lipid profiles, blood pressure, and glucose levels: a systematic review and meta-analysis. Nutr Rev. 2020;78(8):615\u201326. https:\/\/doi.org\/10.1093\/nutrit\/nuz071.","journal-title":"Nutr Rev"},{"issue":"11","key":"4481_CR43","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1080\/10408398.2019.1604491","volume":"60","author":"R Tabrizi","year":"2020","unstructured":"Tabrizi R, Tamtaji OR, Mirhosseini N, et al. The effects of quercetin supplementation on lipid profiles and inflammatory markers among patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2020;60(11):1855\u201368. https:\/\/doi.org\/10.1080\/10408398.2019.1604491.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"2","key":"4481_CR44","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s10557-020-07077-8","volume":"35","author":"S Mao","year":"2021","unstructured":"Mao S, Wang L, Zhao X, et al. Efficacy of Sodium Tanshinone IIA Sulfonate in Patients with Non-ST Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Results from a Multicentre, Controlled, Randomized Trial. Cardiovasc Drugs Ther. 2021;35(2):321\u20139. https:\/\/doi.org\/10.1007\/s10557-020-07077-8.","journal-title":"Cardiovasc Drugs Ther"},{"key":"4481_CR45","doi-asserted-by":"publisher","first-page":"1144419","DOI":"10.3389\/fphar.2023.1144419","volume":"14","author":"Z Kan","year":"2023","unstructured":"Kan Z, Yan W, Yang M, et al. Effects of sodium tanshinone IIA sulfonate injection on inflammatory factors and vascular endothelial function in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A systematic review and meta-analysis of randomized clinical trials. Front Pharmacol. 2023;14:1144419. https:\/\/doi.org\/10.3389\/fphar.2023.1144419.","journal-title":"Front Pharmacol"},{"key":"4481_CR46","doi-asserted-by":"publisher","first-page":"770746","DOI":"10.3389\/fcvm.2021.770746","volume":"8","author":"H Zhou","year":"2021","unstructured":"Zhou H, Zhao Y, Peng W, et al. Effect of Sodium Tanshinone IIA Sulfonate Injection on Blood Lipid in Patients With Coronary Heart Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Front Cardiovasc Med. 2021;8:770746. https:\/\/doi.org\/10.3389\/fcvm.2021.770746.","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"4481_CR47","doi-asserted-by":"publisher","first-page":"e27597","DOI":"10.1016\/j.heliyon.2024.e27597","volume":"10","author":"Y Liang","year":"2024","unstructured":"Liang Y, Fu J, Shi Y, et al. Integration of 16S rRNA sequencing and metabolomics to investigate the modulatory effect of ginsenoside Rb1 on atherosclerosis. Heliyon. 2024;10(6):e27597. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e27597.","journal-title":"Heliyon"},{"key":"4481_CR48","doi-asserted-by":"publisher","first-page":"117004","DOI":"10.1016\/j.biopha.2024.117004","volume":"177","author":"Q Chen","year":"2024","unstructured":"Chen Q, Huang Z, Chen J, et al. Notoginsenoside R1 attenuates ischemic heart failure by modulating MDM2\/\u03b2 arrestin2-mediated \u03b22-adrenergic receptor ubiquitination. Biomed Pharmacother. 2024;177:117004. https:\/\/doi.org\/10.1016\/j.biopha.2024.117004.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"4481_CR49","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1080\/13813455.2019.1671458","volume":"128","author":"M Ashrafizadeh","year":"2022","unstructured":"Ashrafizadeh M, Ahmadi Z, Farkhondeh T, et al. Autophagy as a molecular target of quercetin underlying its protective effects in human diseases. Arch Physiol Biochem. 2022;128(1):200\u20138. https:\/\/doi.org\/10.1080\/13813455.2019.1671458.","journal-title":"Arch Physiol Biochem"},{"issue":"12","key":"4481_CR50","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1007\/s12012-024-09921-x","volume":"24","author":"MM Dabbaghi","year":"2024","unstructured":"Dabbaghi MM, Soleimani Roudi H, Safaei R, et al. Unveiling the Mechanism of Protective Effects of Tanshinone as a New Fighter Against Cardiovascular Diseases: A Systematic Review. Cardiovasc Toxicol. 2024;24(12):1467\u2013509. https:\/\/doi.org\/10.1007\/s12012-024-09921-x.","journal-title":"Cardiovasc Toxicol"},{"key":"4481_CR51","doi-asserted-by":"publisher","first-page":"102152","DOI":"10.1016\/j.mtbio.2025.102152","volume":"34","author":"S Ding","year":"2025","unstructured":"Ding S, Xu W, Liu X, et al. Curcumin-loaded nanoscale coordination polymers for ROS scavenging and anti-inflammatory therapy in atherosclerosis. Mater today Bio. 2025;34:102152. https:\/\/doi.org\/10.1016\/j.mtbio.2025.102152.","journal-title":"Mater today Bio"},{"issue":"1","key":"4481_CR52","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12951-024-02485-6","volume":"22","author":"L Switala","year":"2024","unstructured":"Switala L, Di L, Gao H, et al. Engineered nanoparticles promote cardiac tropism of AAV vectors. J Nanobiotechnol. 2024;22(1):223. https:\/\/doi.org\/10.1186\/s12951-024-02485-6.","journal-title":"J Nanobiotechnol"},{"issue":"2","key":"4481_CR53","doi-asserted-by":"publisher","first-page":"528","DOI":"10.7150\/thno.87739","volume":"14","author":"Z Zhuo","year":"2024","unstructured":"Zhuo Z, Guo K, Luo Y, et al. Targeted modulation of intestinal epithelial regeneration and immune response in ulcerative colitis using dual-targeting bilirubin nanoparticles. Theranostics. 2024;14(2):528\u201346. https:\/\/doi.org\/10.7150\/thno.87739.","journal-title":"Theranostics"},{"issue":"5","key":"4481_CR54","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.7150\/thno.103636","volume":"15","author":"X Shao","year":"2025","unstructured":"Shao X, Zhao X, Wang B, et al. Tumor microenvironment targeted nano-drug delivery systems for multidrug resistant tumor therapy. Theranostics. 2025;15(5):1689\u2013714. https:\/\/doi.org\/10.7150\/thno.103636.","journal-title":"Theranostics"},{"key":"4481_CR55","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.2147\/IJN.S449268","volume":"19","author":"W Nie","year":"2024","unstructured":"Nie W, Liu Y, Lan J, et al. Self-Assembled Nanoparticles from Xie-Bai-San Decoction: Isolation, Characterization and Enhancing Oral Bioavailability. Int J Nanomed. 2024;19:3405\u201321. https:\/\/doi.org\/10.2147\/IJN.S449268. doi: 10.2147\/IJN.S449268.","journal-title":"Int J Nanomed"},{"key":"4481_CR56","doi-asserted-by":"publisher","first-page":"122570","DOI":"10.1016\/j.ijpharm.2022.122570","volume":"632","author":"S Khizar","year":"2023","unstructured":"Khizar S, Alrushaid N, Alam Khan F, et al. Nanocarriers based novel and effective drug delivery system. Int J Pharm. 2023;632:122570. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122570.","journal-title":"Int J Pharm"},{"issue":"1","key":"4481_CR57","doi-asserted-by":"publisher","first-page":"2416550","DOI":"10.1080\/21505594.2024.2416550","volume":"15","author":"PH Fonseca Do Carmo","year":"2024","unstructured":"Fonseca Do Carmo PH, Pinheiro Lage AC, Garcia MT, et al. Resveratrol-coated gold nanorods produced by green synthesis with activity against Candida albicans. Virulence. 2024;15(1):2416550. https:\/\/doi.org\/10.1080\/21505594.2024.2416550.","journal-title":"Virulence"},{"issue":"1","key":"4481_CR58","doi-asserted-by":"publisher","first-page":"2380538","DOI":"10.1080\/10717544.2024.2380538","volume":"31","author":"M Jia","year":"2024","unstructured":"Jia M, Ren W, Wang M, et al. Surface saturation of drug-loaded hollow manganese dioxide nanoparticles with human serum albumin for treating rheumatoid arthritis. Drug Delivery. 2024;31(1):2380538. https:\/\/doi.org\/10.1080\/10717544.2024.2380538.","journal-title":"Drug Delivery"},{"issue":"6","key":"4481_CR59","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/s41565-024-01673-7","volume":"19","author":"BB Mendes","year":"2024","unstructured":"Mendes BB, Zhang Z, Conniot J, et al. A large-scale machine learning analysis of inorganic nanoparticles in preclinical cancer research. Nat Nanotechnol. 2024;19(6):867\u201378. https:\/\/doi.org\/10.1038\/s41565-024-01673-7.","journal-title":"Nat Nanotechnol"},{"key":"4481_CR60","doi-asserted-by":"publisher","first-page":"114097","DOI":"10.1016\/j.colsurfb.2024.114097","volume":"242","author":"PM Ivantcova","year":"2024","unstructured":"Ivantcova PM, Kolychev EL, Sizikov AA, et al. Carbene-coated metal nanoparticles for in vivo applications. Colloids Surf B Biointerfaces. 2024;242:114097. https:\/\/doi.org\/10.1016\/j.colsurfb.2024.114097.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"23","key":"4481_CR61","doi-asserted-by":"publisher","first-page":"27533","DOI":"10.1021\/acsami.1c04063","volume":"13","author":"R Barbir","year":"2021","unstructured":"Barbir R, Jim\u00e9nez RR, Mart\u00edn-Rap\u00fan R, et al. Interaction of Differently Sized, Shaped, and Functionalized Silver and Gold Nanoparticles with Glycosylated versus Nonglycosylated Transferrin. ACS Appl Mater Interfaces. 2021;13(23):27533\u201347. https:\/\/doi.org\/10.1021\/acsami.1c04063.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"8","key":"4481_CR62","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1021\/acs.bioconjchem.1c00211","volume":"32","author":"A Graczyk","year":"2021","unstructured":"Graczyk A, Pawlowska R, Chworos A. Gold Nanoparticles as Carriers for Functional RNA Nanostructures. Bioconjug Chem. 2021;32(8):1667\u201374. https:\/\/doi.org\/10.1021\/acs.bioconjchem.1c00211.","journal-title":"Bioconjug Chem"},{"key":"4481_CR63","doi-asserted-by":"publisher","first-page":"108271","DOI":"10.1016\/j.jmgm.2022.108271","volume":"116","author":"N Farhadian","year":"2022","unstructured":"Farhadian N, Kazemi MS, Moosavi Baigi F, et al. Molecular dynamics simulation of drug delivery across the cell membrane by applying gold nanoparticle carrier: Flutamide as hydrophobic and glutathione as hydrophilic drugs as the case studies. J Mol Graph Model. 2022;116:108271. https:\/\/doi.org\/10.1016\/j.jmgm.2022.108271.","journal-title":"J Mol Graph Model"},{"key":"4481_CR64","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.biomaterials.2016.08.048","volume":"108","author":"X Li","year":"2016","unstructured":"Li X, Wang C, Tan H, et al. Gold nanoparticles-based SPECT\/CT imaging probe targeting for vulnerable atherosclerosis plaques. Biomaterials. 2016;108:71\u201380. https:\/\/doi.org\/10.1016\/j.biomaterials.2016.08.048.","journal-title":"Biomaterials"},{"key":"4481_CR65","doi-asserted-by":"publisher","unstructured":"Huang C, Huang W, Meng Y, et al. T1-weighted MRI of targeting atherosclerotic plaque based on CD40 expression on engulfed USPIO\u2019s cell surface. Biomed Mater. 2024;19(2). https:\/\/doi.org\/10.1088\/1748-605X\/ad1df6.","DOI":"10.1088\/1748-605X\/ad1df6"},{"key":"4481_CR66","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.2147\/IJN.S130951","volume":"12","author":"Y Qiao","year":"2017","unstructured":"Qiao Y, Zhu B, Tian A, et al. PEG-coated gold nanoparticles attenuate \u03b2-adrenergic receptor-mediated cardiac hypertrophy. Int J Nanomed. 2017;12:4709\u201319. https:\/\/doi.org\/10.2147\/IJN.S130951. doi: 10.2147\/IJN.S130951.","journal-title":"Int J Nanomed"},{"issue":"43","key":"4481_CR67","doi-asserted-by":"publisher","first-page":"e2502778","DOI":"10.1002\/smll.202502778","volume":"21","author":"X Chen","year":"2025","unstructured":"Chen X, Chen H, Zhu L, et al. Cascade Nanozyme Delivering miRNA to Ischemic Heart to Alleviate Myocardial Ischemia-Reperfusion Injury. Small. 2025;21(43):e2502778. https:\/\/doi.org\/10.1002\/smll.202502778.","journal-title":"Small"},{"issue":"Pt 3","key":"4481_CR68","doi-asserted-by":"publisher","first-page":"142935","DOI":"10.1016\/j.ijbiomac.2025.142935","volume":"309","author":"X Wang","year":"2025","unstructured":"Wang X, Qian D, Xu L, et al. Green synthesis of AgNPs and their application in chitosan\/polyvinyl alcohol\/AgNPs composite sponges with efficient antibacterial activity for wound healing. Int J Biol Macromol. 2025;309(Pt 3):142935. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.142935.","journal-title":"Int J Biol Macromol"},{"issue":"6","key":"4481_CR69","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3390\/gels10060363","volume":"10","author":"NA O\u2019Connor","year":"2024","unstructured":"O\u2019Connor NA, Syed A, Kastrat E, et al. Antibacterial Silver Nanoparticle Containing Polydopamine Hydrogels That Enhance Re-Epithelization. Gels (Basel. Switzerland). 2024;10(6):363. https:\/\/doi.org\/10.3390\/gels10060363.","journal-title":"Switzerland)"},{"issue":"4","key":"4481_CR70","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1021\/acsbiomaterials.0c00041","volume":"6","author":"S Dai","year":"2020","unstructured":"Dai S, Jiang L, Liu L, et al. Photofunctionalized and Drug-Loaded TiO2 Nanotubes with Improved Vascular Biocompatibility as a Potential Material for Polymer-Free Drug-Eluting Stents. ACS Biomater Sci Eng. 2020;6(4):2038\u201349. https:\/\/doi.org\/10.1021\/acsbiomaterials.0c00041.","journal-title":"ACS Biomater Sci Eng"},{"issue":"Pt 1","key":"4481_CR71","doi-asserted-by":"publisher","first-page":"149558","DOI":"10.1016\/j.ijbiomac.2025.149558","volume":"337","author":"A Kashef Hesary","year":"2025","unstructured":"Kashef Hesary A, Mohammadi Chongaraluo F, Mounesi Rad S, et al. Impregnation of biopolymers containing berberine-loaded nanoliposomes with silver nanoparticles as novel antimicrobial nanocomposite films. Int J Biol Macromol. 2025;337(Pt 1):149558. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.149558.","journal-title":"Int J Biol Macromol"},{"key":"4481_CR72","doi-asserted-by":"publisher","unstructured":"Guo Z, Liu D, Zhang H et al. Superparamagnetic iron oxide nanoparticles in clinical applications: current status and future perspectives. EBioMedicine. 2025;122:106054. https:\/\/doi.org\/10.1016\/j.ebiom.2025.106054. https:\/\/doi.org\/10.1016\/j.ebiom.2025.106054.","DOI":"10.1016\/j.ebiom.2025.106054"},{"issue":"3","key":"4481_CR73","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.7150\/thno.89190","volume":"14","author":"W Yang","year":"2024","unstructured":"Yang W, Wang Y, Fu C, et al. Quantitative visualization of myocardial ischemia-reperfusion-induced cardiac lesions via ferroptosis magnetic particle imaging. Theranostics. 2024;14(3):1081\u201397. https:\/\/doi.org\/10.7150\/thno.89190.","journal-title":"Theranostics"},{"key":"4481_CR74","doi-asserted-by":"publisher","first-page":"598617","DOI":"10.3389\/fnins.2020.598617","volume":"14","author":"E Amanzadeh Jajin","year":"2021","unstructured":"Amanzadeh Jajin E, Esmaeili A, Rahgozar S, et al. Quercetin-Conjugated Superparamagnetic Iron Oxide Nanoparticles Protect AlCl3-Induced Neurotoxicity in a Rat Model of Alzheimer\u2019s Disease via Antioxidant Genes, APP Gene, and miRNA-101. Front Neurosci. 2021;14:598617. https:\/\/doi.org\/10.3389\/fnins.2020.598617.","journal-title":"Front Neurosci"},{"issue":"31","key":"4481_CR75","doi-asserted-by":"publisher","first-page":"e2505540","DOI":"10.1002\/adma.202505540","volume":"37","author":"C Wang","year":"2025","unstructured":"Wang C, Teng T, Ma Y. Liquid Metal: A New Approach to Diagnosis and Treatment of Cardiovascular Diseases. Adv Mater. 2025;37(31):e2505540. https:\/\/doi.org\/10.1002\/adma.202505540.","journal-title":"Adv Mater"},{"issue":"46","key":"4481_CR76","doi-asserted-by":"publisher","first-page":"11916","DOI":"10.1039\/d4tb01274g","volume":"12","author":"L Fan","year":"2024","unstructured":"Fan L, Qu H, Wang B, et al. Delivery of liquid metal particles and tanshinone IIA into the pericardial cavity for myocardial infarction treatment. J Mater Chem B. 2024;12(46):11916\u201325. https:\/\/doi.org\/10.1039\/d4tb01274g.","journal-title":"J Mater Chem B"},{"issue":"1","key":"4481_CR77","doi-asserted-by":"publisher","first-page":"2005361","DOI":"10.1002\/adfm.202005361","volume":"31","author":"I Cockerill","year":"2021","unstructured":"Cockerill I, See CW, Young ML, et al. Designing Better Cardiovascular Stent Materials - A Learning Curve. Adv Funct Mater. 2021;31(1):2005361. https:\/\/doi.org\/10.1002\/adfm.202005361.","journal-title":"Adv Funct Mater"},{"issue":"8","key":"4481_CR78","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1182\/blood.2022018096","volume":"143","author":"A Nascimbene","year":"2024","unstructured":"Nascimbene A, Bark D, Smadja DM. Hemocompatibility and biophysical interface of left ventricular assist devices and total artificial hearts. Blood. 2024;143(8):661\u201372. https:\/\/doi.org\/10.1182\/blood.2022018096.","journal-title":"Blood"},{"key":"4481_CR79","doi-asserted-by":"publisher","first-page":"102223","DOI":"10.1016\/j.mtbio.2025.102223","volume":"34","author":"Y Liu","year":"2025","unstructured":"Liu Y, Zhao M, Zhang M, et al. Mesoporous silica nanoparticle-based nanomedicine: Preparation, functional modification, and theranostic applications. Mater Today Bio. 2025;34:102223. https:\/\/doi.org\/10.1016\/j.mtbio.2025.102223.","journal-title":"Mater Today Bio"},{"issue":"1","key":"4481_CR80","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41392-023-01654-7","volume":"8","author":"B Xu","year":"2023","unstructured":"Xu B, Li S, Shi R, et al. Multifunctional mesoporous silica nanoparticles for biomedical applications. Signal Transduct Target Ther. 2023;8(1):435. https:\/\/doi.org\/10.1038\/s41392-023-01654-7.","journal-title":"Signal Transduct Target Ther"},{"issue":"Pt A","key":"4481_CR81","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jcis.2020.08.010","volume":"582","author":"Y Gao","year":"2021","unstructured":"Gao Y, He Y, Zhang H, et al. Zwitterion-functionalized mesoporous silica nanoparticles for enhancing oral delivery of protein drugs by overcoming multiple gastrointestinal barriers. J Colloid Interface Sci. 2021;582(Pt A):364\u201375. https:\/\/doi.org\/10.1016\/j.jcis.2020.08.010.","journal-title":"J Colloid Interface Sci"},{"key":"4481_CR82","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.2147\/IJN.S238337","volume":"15","author":"G Yang","year":"2020","unstructured":"Yang G, Li Z, Wu F, et al. Improving Solubility and Bioavailability of Breviscapine with Mesoporous Silica Nanoparticles Prepared Using Ultrasound-Assisted Solution-Enhanced Dispersion by Supercritical Fluids Method. Int J Nanomed. 2020;15:1661\u201375. https:\/\/doi.org\/10.2147\/IJN.S238337. doi: 10.2147\/IJN.S238337.","journal-title":"Int J Nanomed"},{"key":"4481_CR83","doi-asserted-by":"publisher","unstructured":"Manzano M, Vallet-Reg\u00ed M. Mesoporous Silica Nanoparticles in Biomedicine: Advances and Prospects. Adv Mater 2025 Aug 25:e12433. https:\/\/doi.org\/10.1002\/adma.202512433. https:\/\/doi.org\/10.1002\/adma.202512433.","DOI":"10.1002\/adma.202512433"},{"key":"4481_CR84","doi-asserted-by":"publisher","first-page":"120677","DOI":"10.1016\/j.biomaterials.2021.120677","volume":"269","author":"LM Pham","year":"2021","unstructured":"Pham LM, Kim EC, Ou W, et al. Targeting and clearance of senescent foamy macrophages and senescent endothelial cells by antibody-functionalized mesoporous silica nanoparticles for alleviating aorta atherosclerosis. Biomaterials. 2021;269:120677. https:\/\/doi.org\/10.1016\/j.biomaterials.2021.120677.","journal-title":"Biomaterials"},{"issue":"24","key":"4481_CR85","doi-asserted-by":"publisher","first-page":"e2501576","DOI":"10.1002\/adma.202501576","volume":"37","author":"Y Liu","year":"2025","unstructured":"Liu Y, Wang C, Wei P, et al. Mesoporous Silica Nanotraps for Mitigating Bleeding Risk From \u2018Irreversible\u2019 Antiplatelet Drugs. Adv Mater. 2025;37(24):e2501576. https:\/\/doi.org\/10.1002\/adma.202501576.","journal-title":"Adv Mater"},{"issue":"1","key":"4481_CR86","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12951-025-03113-7","volume":"23","author":"S Gressler","year":"2025","unstructured":"Gressler S, Hipfinger C, Part F, et al. A systematic review of nanocarriers used in medicine and beyond - definition and categorization framework. J Nanobiotechnol. 2025;23(1):90. https:\/\/doi.org\/10.1186\/s12951-025-03113-7.","journal-title":"J Nanobiotechnol"},{"issue":"6","key":"4481_CR87","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1016\/j.apsb.2022.04.013","volume":"12","author":"Y Li","year":"2022","unstructured":"Li Y, Ye Z, Yang H, et al. Tailoring combinatorial lipid nanoparticles for intracellular delivery of nucleic acids, proteins, and drugs. Acta Pharm Sinica B. 2022;12(6):2624\u201339. https:\/\/doi.org\/10.1016\/j.apsb.2022.04.013.","journal-title":"Acta Pharm Sinica B"},{"issue":"2","key":"4481_CR88","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3390\/pharmaceutics17020144","volume":"17","author":"A Liakopoulou","year":"2025","unstructured":"Liakopoulou A, Letsiou S, Avgoustakis K, et al. Curcumin-Loaded Lipid Nanocarriers: A Targeted Approach for Combating Oxidative Stress in Skin Applications. Pharmaceutics. 2025;17(2):144. https:\/\/doi.org\/10.3390\/pharmaceutics17020144.","journal-title":"Pharmaceutics"},{"issue":"11","key":"4481_CR89","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.3390\/pharmaceutics13111817","volume":"13","author":"SLJ Tan","year":"2021","unstructured":"Tan SLJ, Billa N. Improved Bioavailability of Poorly Soluble Drugs through Gastrointestinal Muco-Adhesion of Lipid Nanoparticles. Pharmaceutics. 2021;13(11):1817. https:\/\/doi.org\/10.3390\/pharmaceutics13111817.","journal-title":"Pharmaceutics"},{"issue":"Pt 7","key":"4481_CR90","doi-asserted-by":"publisher","first-page":"127554","DOI":"10.1016\/j.ijbiomac.2023.127554","volume":"253","author":"Y Hu","year":"2023","unstructured":"Hu Y, Zhang L, Wei LF, et al. Liposomes encapsulation by pH driven improves the stability, bioaccessibility and bioavailability of urolithin A: A comparative study. Int J Biol Macromol. 2023;253(Pt 7):127554. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.127554.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"4481_CR91","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s12951-025-03412-z","volume":"23","author":"DE Uti","year":"2025","unstructured":"Uti DE, Alum EU, Atangwho IJ, et al. Lipid-based nano-carriers for the delivery of anti-obesity natural compounds: advances in targeted delivery and precision therapeutics. J Nanobiotechnol. 2025;23(1):336. https:\/\/doi.org\/10.1186\/s12951-025-03412-z.","journal-title":"J Nanobiotechnol"},{"issue":"6","key":"4481_CR92","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.3390\/pharmaceutics15061593","volume":"15","author":"C Viegas","year":"2023","unstructured":"Viegas C, Patr\u00edcio AB, Prata JM, et al. Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: A Comparative Review. Pharmaceutics. 2023;15(6):1593. https:\/\/doi.org\/10.3390\/pharmaceutics15061593.","journal-title":"Pharmaceutics"},{"issue":"3","key":"4481_CR93","doi-asserted-by":"publisher","first-page":"446","DOI":"10.34172\/apb.2023.056","volume":"13","author":"S Khan","year":"2023","unstructured":"Khan S, Sharma A, Jain V. An Overview of Nanostructured Lipid Carriers and its Application in Drug Delivery through Different Routes. Adv Pharm Bull. 2023;13(3):446\u201360. https:\/\/doi.org\/10.34172\/apb.2023.056.","journal-title":"Adv Pharm Bull"},{"key":"4481_CR94","doi-asserted-by":"publisher","unstructured":"Li Z, Li M, Lu J. Biomimetic liposomes in drug delivery: from design mechanisms to applications. Chem Soc Rev. 2025 Dec;9. https:\/\/doi.org\/10.1039\/d5cs00440c.","DOI":"10.1039\/d5cs00440c"},{"key":"4481_CR95","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.actbio.2025.07.027","volume":"202","author":"N Eczacioglu","year":"2025","unstructured":"Eczacioglu N, Postina A, Ebert M, et al. Self-emulsifying drug delivery systems: A comparison of dry and wet reverse micelles. Acta Biomater. 2025;202:545\u201358. https:\/\/doi.org\/10.1016\/j.actbio.2025.07.027.","journal-title":"Acta Biomater"},{"issue":"5","key":"4481_CR96","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1093\/cvr\/cvaf039","volume":"121","author":"Q Chen","year":"2025","unstructured":"Chen Q, Yu Y, Tong L, et al. Targeted delivery of TAPI-1 via biomimetic nanoparticles ameliorates post-infarct left ventricle function and remodelling. Cardiovasc Res. 2025;121(5):760\u201374. https:\/\/doi.org\/10.1093\/cvr\/cvaf039.","journal-title":"Cardiovasc Res"},{"key":"4481_CR97","doi-asserted-by":"publisher","first-page":"7965","DOI":"10.2147\/IJN.S430769","volume":"18","author":"L Sheng","year":"2023","unstructured":"Sheng L, Wei Y, Pi C, Zheng W, Zhao L, et al. Preparation and Evaluation of Curcumin Derivatives Nanoemulsion Based on Turmeric Extract and Its Antidepressant Effect. Int J Nanomed. 2023;18:7965\u201383. https:\/\/doi.org\/10.2147\/IJN.S430769. doi: 10.2147\/IJN.S430769.","journal-title":"Int J Nanomed"},{"issue":"Pt 4","key":"4481_CR98","doi-asserted-by":"publisher","first-page":"134404","DOI":"10.1016\/j.ijbiomac.2024.134404","volume":"277","author":"J Xu","year":"2024","unstructured":"Xu J, Hu H, Qian X, et al. Therapeutic effects of chamomile volatile oil nanoemulsion\/Bletilla striata polysaccharides gels on atopic dermatitis. Int J Biol Macromol. 2024;277(Pt 4):134404. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.134404.","journal-title":"Int J Biol Macromol"},{"issue":"9","key":"4481_CR99","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.3390\/pharmaceutics16091116","volume":"16","author":"X Chen","year":"2024","unstructured":"Chen X, Yang H, Shi L, et al. Self-Microemulsifying Drug Delivery System to Enhance Oral Bioavailability of Berberine Hydrochloride in Rats. Pharmaceutics. 2024;16(9):1116. https:\/\/doi.org\/10.3390\/pharmaceutics16091116.","journal-title":"Pharmaceutics"},{"issue":"1","key":"4481_CR100","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/17425247.2023.2154075","volume":"20","author":"X Wang","year":"2023","unstructured":"Wang X, Anton H, Vandamme T, et al. Updated insight into the characterization of nano-emulsions. Expert Opin Drug Deliv. 2023;20(1):93\u2013114. https:\/\/doi.org\/10.1080\/17425247.2023.2154075.","journal-title":"Expert Opin Drug Deliv"},{"key":"4481_CR101","doi-asserted-by":"publisher","first-page":"123408","DOI":"10.1016\/j.carbpol.2025.123408","volume":"356","author":"W Wang","year":"2025","unstructured":"Wang W, Liu X, Gao X, et al. Characterization, digestive properties and glucose metabolism regulation of curcumin-loaded Pickering emulsion. Carbohydr Polym. 2025;356:123408. https:\/\/doi.org\/10.1016\/j.carbpol.2025.123408.","journal-title":"Carbohydr Polym"},{"key":"4481_CR102","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ijbiomac.2020.02.248","volume":"152","author":"Y Fan","year":"2020","unstructured":"Fan Y, Zeng X, Yi J, et al. Fabrication of pea protein nanoparticles with calcium-induced cross-linking for the stabilization and delivery of antioxidative resveratrol. Int J Biol Macromol. 2020;152:189\u201398. https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.02.248.","journal-title":"Int J Biol Macromol"},{"issue":"18","key":"4481_CR103","doi-asserted-by":"publisher","first-page":"16922","DOI":"10.1021\/acsami.9b02529","volume":"11","author":"S Chen","year":"2019","unstructured":"Chen S, Han Y, Huang J, et al. Fabrication and Characterization of Layer-by-Layer Composite Nanoparticles Based on Zein and Hyaluronic Acid for Codelivery of Curcumin and Quercetagetin. ACS Appl Mater Interfaces. 2019;11(18):16922\u201333. https:\/\/doi.org\/10.1021\/acsami.9b02529.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"8","key":"4481_CR104","doi-asserted-by":"publisher","first-page":"7721","DOI":"10.1021\/acsnano.3c00288","volume":"17","author":"Y Liu","year":"2023","unstructured":"Liu Y, He M, Yuan Y, et al. Neutrophil-Membrane-Coated Biomineralized Metal-Organic Framework Nanoparticles for Atherosclerosis Treatment by Targeting Gene Silencing. ACS Nano. 2023;17(8):7721\u201332. https:\/\/doi.org\/10.1021\/acsnano.3c00288.","journal-title":"ACS Nano"},{"key":"4481_CR105","doi-asserted-by":"publisher","first-page":"121297","DOI":"10.1016\/j.ijpharm.2021.121297","volume":"611","author":"JW Shen","year":"2022","unstructured":"Shen JW, Li C, Yang MY, et al. Biomimetic nanoparticles: U937 cell membranes based core-shell nanosystems for targeted atherosclerosis therapy. Int J Pharm. 2022;611:121297. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.121297.","journal-title":"Int J Pharm"},{"issue":"47","key":"4481_CR106","doi-asserted-by":"publisher","first-page":"40426","DOI":"10.1021\/acsnano.5c12456","volume":"19","author":"S Wang","year":"2025","unstructured":"Wang S, Xie X, Tang L, et al. Biomimetic Macrophages Inhibit Atherosclerosis in ApoE-\/- Mice through Inducing Macrophages Autophagy. ACS Nano. 2025;19(47):40426\u201339. https:\/\/doi.org\/10.1021\/acsnano.5c12456.","journal-title":"ACS Nano"},{"issue":"1","key":"4481_CR107","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1186\/s12951-022-01746-6","volume":"20","author":"Y Wu","year":"2022","unstructured":"Wu Y, Wan S, Yang S, et al. Macrophage cell membrane-based nanoparticles: a new promising biomimetic platform for targeted delivery and treatment. J Nanobiotechnol. 2022;20(1):542. https:\/\/doi.org\/10.1186\/s12951-022-01746-6.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"4481_CR108","doi-asserted-by":"publisher","first-page":"164","DOI":"10.7150\/thno.47841","volume":"11","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhang K, Li T, et al. Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications. Theranostics. 2021;11(1):164\u201380. https:\/\/doi.org\/10.7150\/thno.47841.","journal-title":"Theranostics"},{"key":"4481_CR109","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.bioactmat.2025.09.022","volume":"55","author":"S Cai","year":"2025","unstructured":"Cai S, Gao J, Weng X, et al. Synergistic enhancement of efferocytosis and cholesterol efflux via macrophage biomimetic nanoparticle to attenuate atherosclerosis progression. Bioact Mater. 2025;55:131\u201343. https:\/\/doi.org\/10.1016\/j.bioactmat.2025.09.022.","journal-title":"Bioact Mater"},{"issue":"28","key":"4481_CR110","doi-asserted-by":"publisher","first-page":"25628","DOI":"10.1021\/acsnano.5c00216","volume":"19","author":"X Dong","year":"2025","unstructured":"Dong X, Suo Y, Yu J, et al. Biomimetic Nanoparticles Simultaneously Targeting Modulation of Lipid Metabolism and Phenotype of Macrophages for Programmed Atherosclerosis Management. ACS Nano. 2025;19(28):25628\u201344. https:\/\/doi.org\/10.1021\/acsnano.5c00216.","journal-title":"ACS Nano"},{"key":"4481_CR111","doi-asserted-by":"publisher","unstructured":"De R, Mahata MK, Kim KT. Structure-Based Varieties of Polymeric Nanocarriers and Influences of Their Physicochemical Properties on Drug Delivery Profiles. Advanced science (Weinheim, Baden-Wurttemberg, Germany). 2022;9(10):e2105373. https:\/\/doi.org\/10.1002\/advs.202105373. https:\/\/doi.org\/10.1002\/advs.202105373.","DOI":"10.1002\/advs.202105373"},{"issue":"9","key":"4481_CR112","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.1021\/acs.chemrev.3c00705","volume":"124","author":"MA Beach","year":"2024","unstructured":"Beach MA, Nayanathara U, Gao Y, et al. Polymeric Nanoparticles for Drug Delivery. Chem Rev. 2024;124(9):5505\u2013616. https:\/\/doi.org\/10.1021\/acs.chemrev.3c00705.","journal-title":"Chem Rev"},{"issue":"11","key":"4481_CR113","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1038\/s41565-024-01727-w","volume":"19","author":"AC Wauters","year":"2024","unstructured":"Wauters AC, Scheerstra JF, van Leent MMT, et al. Polymersomes with splenic avidity target red pulp myeloid cells for cancer immunotherapy. Nat Nanotechnol. 2024;19(11):1735\u201344. https:\/\/doi.org\/10.1038\/s41565-024-01727-w.","journal-title":"Nat Nanotechnol"},{"issue":"3","key":"4481_CR114","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1021\/acs.biomac.1c01403","volume":"23","author":"C Ade","year":"2022","unstructured":"Ade C, Qian X, Brodszkij E, et al. Polymer Micelles vs Polymer-Lipid Hybrid Vesicles: A Comparison Using RAW 264.7 Cells. Biomacromolecules. 2022;23(3):1052\u201364. https:\/\/doi.org\/10.1021\/acs.biomac.1c01403.","journal-title":"Biomacromolecules"},{"key":"4481_CR115","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ejpb.2023.01.020","volume":"184","author":"M de Prinse","year":"2023","unstructured":"de Prinse M, Qi R, Amsden BG. Polymer micelles for the protection and delivery of specialized pro-resolving mediators. Eur J Pharm Biopharm. 2023;184:159\u201369. https:\/\/doi.org\/10.1016\/j.ejpb.2023.01.020.","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"4481_CR116","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3390\/pharmaceutics14020258","volume":"14","author":"BH Leal","year":"2022","unstructured":"Leal BH, Velasco B, Camb\u00f3n A, et al. Combined Therapeutics for Atherosclerosis Treatment Using Polymeric Nanovectors. Pharmaceutics. 2022;14(2):258. https:\/\/doi.org\/10.3390\/pharmaceutics14020258.","journal-title":"Pharmaceutics"},{"issue":"3","key":"4481_CR117","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1166\/jbn.2020.2900","volume":"16","author":"H Zhou","year":"2020","unstructured":"Zhou H, Shan Y, Tong F, et al. Resveratrol Nanoparticle Complex: Potential Therapeutic Applications in Myocardial Ischemia Reperfusion Injury. J Biomed Nanotechnol. 2020;16(3):382\u20139. https:\/\/doi.org\/10.1166\/jbn.2020.2900.","journal-title":"J Biomed Nanotechnol"},{"issue":"1","key":"4481_CR118","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1186\/s12951-025-03850-9","volume":"23","author":"Y Jang","year":"2025","unstructured":"Jang Y, Babu A, Chahal S, et al. AI-guided design of a CXCR4-targeted core-shell nanocarrier for co-delivery of berberine\/paclitaxel in cancer therapy. J Nanobiotechnol. 2025;23(1):773. https:\/\/doi.org\/10.1186\/s12951-025-03850-9.","journal-title":"J Nanobiotechnol"},{"key":"4481_CR119","doi-asserted-by":"publisher","first-page":"113650","DOI":"10.1016\/j.biopha.2022.113650","volume":"155","author":"J Yan","year":"2022","unstructured":"Yan J, Guo J, Wang Y, et al. Acute myocardial infarction therapy using calycosin and tanshinone co-loaded mitochondria targeted lipid-polymer hybrid nano-system: Preparation, characterization, and anti myocardial infarction activity assessment. Biomed Pharmacother. 2022;155:113650. https:\/\/doi.org\/10.1016\/j.biopha.2022.113650.","journal-title":"Biomed Pharmacother"},{"issue":"35","key":"4481_CR120","doi-asserted-by":"publisher","first-page":"e2403388","DOI":"10.1002\/advs.202403388","volume":"11","author":"X Guo","year":"2024","unstructured":"Guo X, Luo W, Wu L, et al. Natural Products from Herbal Medicine Self-Assemble into Advanced Bioactive Materials. Adv Sci (Weinh). 2024;11(35):e2403388. https:\/\/doi.org\/10.1002\/advs.202403388.","journal-title":"Adv Sci (Weinh)"},{"issue":"3","key":"4481_CR121","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1021\/acsnano.9b08142","volume":"14","author":"YH Cheng","year":"2020","unstructured":"Cheng YH, He C, Riviere JE, et al. Meta-Analysis of Nanoparticle Delivery to Tumors Using a Physiologically Based Pharmacokinetic Modeling and Simulation Approach. ACS Nano. 2020;14(3):3075\u201395. https:\/\/doi.org\/10.1021\/acsnano.9b08142.","journal-title":"ACS Nano"},{"issue":"6","key":"4481_CR122","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.1039\/d0nr07145e","volume":"13","author":"MV Cano-Cortes","year":"2021","unstructured":"Cano-Cortes MV, Altea-Manzano P, Laz-Ruiz JA, et al. An effective polymeric nanocarrier that allows for active targeting and selective drug delivery in cell coculture systems. Nanoscale. 2021;13(6):3500\u201311. https:\/\/doi.org\/10.1039\/d0nr07145e.","journal-title":"Nanoscale"},{"issue":"1","key":"4481_CR123","doi-asserted-by":"publisher","first-page":"6058","DOI":"10.1038\/s41467-024-50312-1","volume":"15","author":"H Weng","year":"2024","unstructured":"Weng H, Zou W, Tian F, et al. Inhalable cardiac targeting peptide modified nanomedicine prevents pressure overload heart failure in male mice. Nat Commun. 2024;15(1):6058. https:\/\/doi.org\/10.1038\/s41467-024-50312-1.","journal-title":"Nat Commun"},{"key":"4481_CR124","doi-asserted-by":"publisher","first-page":"102930","DOI":"10.1016\/j.cis.2023.102930","volume":"317","author":"S Kans\u0131z","year":"2023","unstructured":"Kans\u0131z S, El\u00e7in YM. Advanced liposome and polymersome-based drug delivery systems: Considerations for physicochemical properties, targeting strategies and stimuli-sensitive approaches. Adv Colloid Interface Sci. 2023;317:102930. https:\/\/doi.org\/10.1016\/j.cis.2023.102930.","journal-title":"Adv Colloid Interface Sci"},{"issue":"26","key":"4481_CR125","doi-asserted-by":"publisher","first-page":"30359","DOI":"10.1021\/acsami.1c07037","volume":"13","author":"RH Kang","year":"2021","unstructured":"Kang RH, Kim Y, Kim JH, et al. Self-Activating Therapeutic Nanoparticle: A Targeted Tumor Therapy Using Reactive Oxygen Species Self-Generation and Switch-on Drug Release. ACS Appl Mater Interfaces. 2021;13(26):30359\u201372. https:\/\/doi.org\/10.1021\/acsami.1c07037.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"4","key":"4481_CR126","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s40005-022-00573-z","volume":"52","author":"J Shinn","year":"2022","unstructured":"Shinn J, Kwon N, Lee SA, et al. Smart pH-responsive nanomedicines for disease therapy. J Pharm Invest. 2022;52(4):427\u201341. https:\/\/doi.org\/10.1007\/s40005-022-00573-z.","journal-title":"J Pharm Invest"},{"issue":"52","key":"4481_CR127","doi-asserted-by":"publisher","first-page":"e2105348","DOI":"10.1002\/adma.202105348","volume":"33","author":"X Li","year":"2021","unstructured":"Li X, Zhang Y, Ren X, et al. Ischemic Microenvironment-Responsive Therapeutics for Cardiovascular Diseases. Adv Mater (Deerfield Beach Fla). 2021;33(52):e2105348. https:\/\/doi.org\/10.1002\/adma.202105348.","journal-title":"Adv Mater (Deerfield Beach Fla)"},{"issue":"26","key":"4481_CR128","doi-asserted-by":"publisher","first-page":"30359","DOI":"10.1021\/acsami.1c07037","volume":"13","author":"RH Kang","year":"2021","unstructured":"Kang RH, Kim Y, Kim JH, et al. Self-Activating Therapeutic Nanoparticle: A Targeted Tumor Therapy Using Reactive Oxygen Species Self-Generation and Switch-on Drug Release. ACS Appl Mater Interfaces. 2021;13(26):30359\u201372. https:\/\/doi.org\/10.1021\/acsami.1c07037.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"23","key":"4481_CR129","doi-asserted-by":"publisher","first-page":"21757","DOI":"10.1021\/acsnano.5c05477","volume":"19","author":"J Zhao","year":"2025","unstructured":"Zhao J, Jia F, Li J, et al. Sprayable Reactive Oxygen Species-Responsive Hydrogel Coatings Restore Endothelial Barrier Integrity for Functional Vascular Healing. ACS Nano. 2025;19(23):21757\u201374. https:\/\/doi.org\/10.1021\/acsnano.5c05477.","journal-title":"ACS Nano"},{"issue":"1","key":"4481_CR130","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12951-025-03183-7","volume":"23","author":"C Wang","year":"2025","unstructured":"Wang C, Cheng H, Dong X, et al. Early assessment and treatment of ventricular remodeling in vivo via a targeted ultrasonic molecular probe loaded with oxygen and cholecystokinin. J Nanobiotechnol. 2025;23(1):104. https:\/\/doi.org\/10.1186\/s12951-025-03183-7.","journal-title":"J Nanobiotechnol"},{"key":"4481_CR131","doi-asserted-by":"publisher","first-page":"102226","DOI":"10.1016\/j.mtbio.2025.102226","volume":"34","author":"N Xu","year":"2025","unstructured":"Xu N, Chi Z, Zhang H, et al. CD11b-modified ROS\/pH-responsive nanoparticles co-deliver Dioscin and siRNA to improve cardiac repair after myocardial infarction by reducing neutrophil recruitment. Mater Today Bio. 2025;34:102226. https:\/\/doi.org\/10.1016\/j.mtbio.2025.102226.","journal-title":"Mater Today Bio"},{"key":"4481_CR132","doi-asserted-by":"publisher","first-page":"102682","DOI":"10.1016\/j.mtbio.2025.102682","volume":"36","author":"JE Liu","year":"2025","unstructured":"Liu JE, Cheng Z, Zhao P, et al. PRP-loaded pH-responsive hydrogel for the amelioration of ventricular remodeling following myocardial infarction. Mater Today Bio. 2025;36:102682. https:\/\/doi.org\/10.1016\/j.mtbio.2025.102682.","journal-title":"Mater Today Bio"},{"issue":"3","key":"4481_CR133","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2174\/1570159X20666220706121412","volume":"21","author":"S Sharma","year":"2023","unstructured":"Sharma S, Dang S. Nanocarrier-Based Drug Delivery to Brain: Interventions of Surface Modification. Curr Neuropharmacol. 2023;21(3):517\u201335. https:\/\/doi.org\/10.2174\/1570159X20666220706121412. doi: 10.2174\/1570159X20666220706121412.","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"4481_CR134","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1038\/s41467","volume":"11","author":"BF Moon","year":"2020","unstructured":"Moon BF, Iyer SK, Hwuang E, et al. Iron imaging in myocardial infarction reperfusion injury. Nat Commun. 2020;11(1):3273. https:\/\/doi.org\/10.1038\/s41467. -020-16923-0.","journal-title":"Nat Commun"},{"issue":"1","key":"4481_CR135","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1080\/10717544.2021.1968977","volume":"28","author":"Y Du","year":"2021","unstructured":"Du Y, Gao J, Zhang H, et al. Brain-targeting delivery of MMB4 DMS using carrier-free nanomedicine CRT-MMB4@MDZ. Drug Delivery. 2021;28(1):1822\u201335. https:\/\/doi.org\/10.1080\/10717544.2021.1968977.","journal-title":"Drug Delivery"},{"issue":"19","key":"4481_CR136","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1161\/CIRCULATIONAHA.122.060257","volume":"147","author":"W Cai","year":"2023","unstructured":"Cai W, Liu L, Shi X, et al. Alox15\/15-HpETE Aggravates Myocardial Ischemia-Reperfusion Injury by Promoting Cardiomyocyte Ferroptosis. Circulation. 2023;147(19):1444\u201360. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.060257.","journal-title":"Circulation"},{"issue":"33","key":"4481_CR137","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1093\/eurheartj\/ehaf374","volume":"46","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Linkermann A, Takahashi M, et al. Ferroptosis in cardiovascular disease: regulatory mechanisms and therapeutic implications. Eur Heart J. 2025;46(33):3247\u201360. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf374.","journal-title":"Eur Heart J"},{"issue":"3","key":"4481_CR138","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/cvr\/cvz145","volume":"116","author":"P Boisgu\u00e9rin","year":"2020","unstructured":"Boisgu\u00e9rin P, Covinhes A, Gallot L, et al. A novel therapeutic peptide targeting myocardial reperfusion injury. Cardiovasc Res. 2020;116(3):633\u201344. https:\/\/doi.org\/10.1093\/cvr\/cvz145.","journal-title":"Cardiovasc Res"},{"issue":"5","key":"4481_CR139","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.kint.2023.01.025","volume":"103","author":"S Qin","year":"2023","unstructured":"Qin S, Liu C, Chen Y, et al. Cobaltosic oxide-polyethylene glycol-triphenylphosphine nanoparticles ameliorate the acute-to-chronic kidney disease transition by inducing BNIP3-mediated mitophagy. Kidney Int. 2023;103(5):903\u201316. https:\/\/doi.org\/10.1016\/j.kint.2023.01.025.","journal-title":"Kidney Int"},{"issue":"5","key":"4481_CR140","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S1875-5364(25)60861-2","volume":"23","author":"Y Wang","year":"2025","unstructured":"Wang Y, Huang R, Feng S, et al. Advances in nanocarriers for targeted drug delivery and controlled drug release. Chin J Nat Med. 2025;23(5):513\u201328. https:\/\/doi.org\/10.1016\/S1875-5364(25)60861-2. doi: 10.1016\/S1875-5364(25)60861-2.","journal-title":"Chin J Nat Med"},{"issue":"8","key":"4481_CR141","doi-asserted-by":"publisher","first-page":"e2500348","DOI":"10.1002\/smtd.202500348","volume":"9","author":"S Yu","year":"2025","unstructured":"Yu S, Baimanov D, Guo Z, et al. In Situ Analysis for Protein Corona: from Morphology, Composition, Structure to Dynamic Process. Small Methods. 2025;9(8):e2500348. https:\/\/doi.org\/10.1002\/smtd.202500348.","journal-title":"Small Methods"},{"issue":"18","key":"4481_CR142","doi-asserted-by":"publisher","first-page":"e1907574","DOI":"10.1002\/smll.201907574","volume":"16","author":"I Alberg","year":"2020","unstructured":"Alberg I, Kramer S, Schinnerer M, et al. Polymeric Nanoparticles with Neglectable Protein Corona. Small. 2020;16(18):e1907574. https:\/\/doi.org\/10.1002\/smll.201907574.","journal-title":"Small"},{"issue":"1","key":"4481_CR143","doi-asserted-by":"publisher","first-page":"39650","DOI":"10.1038\/s41598-025-23355-7","volume":"15","author":"S Zawadzki","year":"2025","unstructured":"Zawadzki S, Ok\u0142a E, Michlewska S, et al. Structural and conformational rearrangements of human serum albumin, transferrin, and blood plasma induced by carbosilane dendrimer therapeutic delivery system. Sci Rep. 2025;15(1):39650. https:\/\/doi.org\/10.1038\/s41598-025-23355-7.","journal-title":"Sci Rep"},{"key":"4481_CR144","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.2147\/IJN.S452824","volume":"19","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Yu M, Song ZF, et al. Targeted Delivery of Mesenchymal Stem Cell-Derived Bioinspired Exosome-Mimetic Nanovesicles with Platelet Membrane Fusion for Atherosclerotic Treatment. Int J Nanomed. 2024;19:2553\u201371. https:\/\/doi.org\/10.2147\/IJN.S452824. doi: 10.2147\/IJN.S452824.","journal-title":"Int J Nanomed"},{"key":"4481_CR145","doi-asserted-by":"publisher","unstructured":"Tang Y, Tian Y, Wang Y et al. Platelet-mitochondria dual-targeted nanocarriers for enhanced empagliflozin therapy in atherosclerosis. Frontiers in bioengineering and biotechnology. 2025;13:1638034. https:\/\/doi.org\/10.3389\/fbioe.2025.1638034. https:\/\/doi.org\/10.3389\/fbioe.2025.1638034.","DOI":"10.3389\/fbioe.2025.1638034"},{"issue":"24","key":"4481_CR146","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","volume":"41","author":"J Bor\u00e9n","year":"2020","unstructured":"Bor\u00e9n J, Chapman MJ, Krauss RM, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2020;41(24):2313\u201330. https:\/\/doi.org\/10.1093\/eurheartj\/ehz962.","journal-title":"Eur Heart J"},{"key":"4481_CR147","doi-asserted-by":"publisher","unstructured":"Cai Y, Li Z. Mathematical modeling of plaque progression and associated microenvironment: How far from predicting the fate of atherosclerosis? Computer methods and programs in biomedicine. 2021;211:106435. https:\/\/doi.org\/10.1016\/j.cmpb.2021.106435. https:\/\/doi.org\/10.1016\/j.cmpb.2021.106435.","DOI":"10.1016\/j.cmpb.2021.106435"},{"key":"4481_CR148","doi-asserted-by":"publisher","first-page":"105364","DOI":"10.1016\/j.phrs.2020.105364","volume":"164","author":"MA Ansari","year":"2021","unstructured":"Ansari MA, Khan FB, Safdari HA, et al. Prospective therapeutic potential of Tanshinone IIA: An updated overview. Pharmacol Res. 2021;164:105364. https:\/\/doi.org\/10.1016\/j.phrs.2020.105364.","journal-title":"Pharmacol Res"},{"key":"4481_CR149","doi-asserted-by":"publisher","first-page":"115501","DOI":"10.1016\/j.biopha.2023.115501","volume":"167","author":"X Ma","year":"2023","unstructured":"Ma X, Zhang L, Gao F, et al. Salvia miltiorrhiza and Tanshinone IIA reduce endothelial inflammation and atherosclerotic plaque formation through inhibiting COX-2. Biomed Pharmacother. 2023;167:115501. https:\/\/doi.org\/10.1016\/j.biopha.2023.115501.","journal-title":"Biomed Pharmacother"},{"key":"4481_CR150","doi-asserted-by":"publisher","first-page":"6293","DOI":"10.2147\/JIR.S386470","volume":"15","author":"J Zhu","year":"2022","unstructured":"Zhu J, Chen H, Guo J, et al. Sodium Tanshinone IIA Sulfonate Inhibits Vascular Endothelial Cell Pyroptosis via the AMPK Signaling Pathway in Atherosclerosis. J Inflamm Res. 2022;15:6293\u2013306. https:\/\/doi.org\/10.2147\/JIR.S386470. doi: 10.2147\/JIR.S386470.","journal-title":"J Inflamm Res"},{"key":"4481_CR151","doi-asserted-by":"publisher","first-page":"1233709","DOI":"10.3389\/fphar.2023.1233709","volume":"14","author":"J Wang","year":"2023","unstructured":"Wang J, Zhang Y, Feng X, et al. Tanshinone IIA alleviates atherosclerosis in LDLR-\/- mice by regulating efferocytosis of macrophages. Front Pharmacol. 2023;14:1233709. https:\/\/doi.org\/10.3389\/fphar.2023.1233709.","journal-title":"Front Pharmacol"},{"key":"4481_CR152","doi-asserted-by":"publisher","first-page":"109362","DOI":"10.1016\/j.biopha.2019.109362","volume":"118","author":"ZY Zhou","year":"2019","unstructured":"Zhou ZY, Zhao WR, Zhang J, et al. Sodium tanshinone IIA sulfonate: A review of pharmacological activity and pharmacokinetics. Biomed Pharmacother. 2019;118:109362. https:\/\/doi.org\/10.1016\/j.biopha.2019.109362.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"4481_CR153","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.1038\/s41598-017-02747-4","volume":"7","author":"L Xing","year":"2017","unstructured":"Xing L, Tan ZR, Cheng JL, et al. Bioavailability and pharmacokinetic comparison of tanshinones between two formulations of Salvia miltiorrhiza in healthy volunteers. Sci Rep. 2017;7(1):4709. https:\/\/doi.org\/10.1038\/s41598-017-02747-4.","journal-title":"Sci Rep"},{"key":"4481_CR154","doi-asserted-by":"publisher","unstructured":"Zhang WL, Xiao Y, Liu JP et al. Structure and remodeling behavior of drug-loaded high density lipoproteins and their atherosclerotic plaque targeting mechanism in foam cell model. International journal of pharmaceutics. 2011;419(1\u20132):314\u2009\u2013\u200921. https:\/\/doi.org\/10.1016\/j.ijpharm.2011.07.039. https:\/\/doi.org\/10.1016\/j.ijpharm.2011.07.039.","DOI":"10.1016\/j.ijpharm.2011.07.039"},{"issue":"1","key":"4481_CR155","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.biomaterials.2012.09.058","volume":"34","author":"W Zhang","year":"2013","unstructured":"Zhang W, He H, Liu J, et al. Pharmacokinetics and atherosclerotic lesions targeting effects of tanshinone IIA discoidal and spherical biomimetic high density lipoproteins. Biomaterials. 2013;34(1):306\u201319. https:\/\/doi.org\/10.1016\/j.biomaterials.2012.09.058.","journal-title":"Biomaterials"},{"key":"4481_CR156","doi-asserted-by":"publisher","first-page":"125228","DOI":"10.1016\/j.ijpharm.2025.125228","volume":"671","author":"Y Chen","year":"2025","unstructured":"Chen Y, Pan D, Zhu Q, et al. Biomimetic metal-phenolic nanocarrier for co-delivery of multiple phytomedical bioactive components for anti-atherosclerotic therapy. Int J Pharm. 2025;671:125228. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125228.","journal-title":"Int J Pharm"},{"issue":"9","key":"4481_CR157","doi-asserted-by":"publisher","first-page":"4478","DOI":"10.1021\/acs.molpharmaceut.3c00127","volume":"20","author":"Q Tang","year":"2023","unstructured":"Tang Q, Chen Y, Zhang Y, et al. ROS-Responsive Prodrug Micelle Co-Delivery System for Synergistic Antiatherosclerotic Therapy. Mol Pharm. 2023;20(9):4478\u201390. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.3c00127.","journal-title":"Mol Pharm"},{"key":"4481_CR158","doi-asserted-by":"publisher","first-page":"1164547","DOI":"10.3389\/fcvm.2023.1164547","volume":"10","author":"W Lu","year":"2023","unstructured":"Lu W, Lin Y, Haider N, et al. Ginsenoside Rb1 protects human vascular smooth muscle cells against resistin-induced oxidative stress and dysfunction. Front Cardiovasc Med. 2023;10:1164547. https:\/\/doi.org\/10.3389\/fcvm.2023.1164547.","journal-title":"Front Cardiovasc Med"},{"issue":"16","key":"4481_CR159","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1016\/j.jacc.2020.08.047","volume":"76","author":"F Chaudhry","year":"2020","unstructured":"Chaudhry F, Kawai H, Johnson KW, et al. Molecular Imaging of Apoptosis in Atherosclerosis by Targeting Cell Membrane Phospholipid Asymmetry. J Am Coll Cardiol. 2020;76(16):1862\u201374. https:\/\/doi.org\/10.1016\/j.jacc.2020.08.047.","journal-title":"J Am Coll Cardiol"},{"key":"4481_CR160","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.jconrel.2022.07.021","volume":"349","author":"F Gong","year":"2022","unstructured":"Gong F, Wang Z, Mo R, et al. Nano-sponge-like liposomes remove cholesterol crystals for antiatherosclerosis. J controlled release: official J Controlled Release Soc. 2022;349:940\u201353. https:\/\/doi.org\/10.1016\/j.jconrel.2022.07.021.","journal-title":"J controlled release: official J Controlled Release Soc"},{"issue":"24","key":"4481_CR161","doi-asserted-by":"publisher","first-page":"9760","DOI":"10.3390\/ijms21249760","volume":"21","author":"L Wang","year":"2020","unstructured":"Wang L, Tang C. Targeting Platelet in Atherosclerosis Plaque Formation: Current Knowledge and Future Perspectives. Int J Mol Sci. 2020;21(24):9760. https:\/\/doi.org\/10.3390\/ijms21249760.","journal-title":"Int J Mol Sci"},{"key":"4481_CR162","doi-asserted-by":"publisher","first-page":"112464","DOI":"10.1016\/j.colsurfb.2022.112464","volume":"214","author":"M Yin","year":"2022","unstructured":"Yin M, Lin J, Yang M, et al. Platelet membrane-cloaked selenium\/ginsenoside Rb1 nanosystem as biomimetic reactor for atherosclerosis therapy. Colloids Surf B Biointerfaces. 2022;214:112464. https:\/\/doi.org\/10.1016\/j.colsurfb.2022.112464.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"sup1","key":"4481_CR163","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1080\/10408398.2018.1501657","volume":"59","author":"Y Dai","year":"2019","unstructured":"Dai Y, Chen SR, Chai L, et al. Overview of pharmacological activities of Andrographis paniculata and its major compound andrographolide. Crit Rev Food Sci Nutr. 2019;59(sup1):S17\u201329. https:\/\/doi.org\/10.1080\/10408398.2018.1501657.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"4481_CR164","doi-asserted-by":"publisher","first-page":"124705","DOI":"10.1016\/j.ijpharm.2024.124705","volume":"665","author":"M Liu","year":"2024","unstructured":"Liu M, Yao C, Liu S, et al. Intelligent response micelles with high andrographolide loading for the effective treatment of atherosclerosis. Int J Pharm. 2024;665:124705. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124705.","journal-title":"Int J Pharm"},{"issue":"7","key":"4481_CR165","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/j.nano.2018.06.010","volume":"14","author":"T Wu","year":"2018","unstructured":"Wu T, Chen X, Wang Y, et al. Aortic plaque-targeted andrographolide delivery with oxidation-sensitive micelle effectively treats atherosclerosis via simultaneous ROS capture and anti-inflammation. Nanomedicine: Nanatechnol biology Med. 2018;14(7):2215\u201326. https:\/\/doi.org\/10.1016\/j.nano.2018.06.010. https:\/\/doi.org\/10.1016\/j.nano.2018.06.010.","journal-title":"Nanomedicine: Nanatechnol biology Med"},{"key":"4481_CR166","doi-asserted-by":"publisher","first-page":"113633","DOI":"10.1016\/j.jconrel.2025.113633","volume":"381","author":"H Zhang","year":"2025","unstructured":"Zhang H, Tian Y, Ren Y, et al. Shear force and cholesterol affinity responsive drug delivery system for treating inflammation and abnormal lipid metabolism in atherosclerosis. J Control Release. 2025;381:113633. https:\/\/doi.org\/10.1016\/j.jconrel.2025.113633.","journal-title":"J Control Release"},{"issue":"1","key":"4481_CR167","doi-asserted-by":"publisher","first-page":"e021682","DOI":"10.1161\/JAHA.121.021682","volume":"11","author":"SS Dani","year":"2022","unstructured":"Dani SS, Lone AN, Javed Z, et al. Trends in Premature Mortality From Acute Myocardial Infarction in the United States, 1999 to 2019. J Am Heart Association. 2022;11(1):e021682. https:\/\/doi.org\/10.1161\/JAHA.121.021682.","journal-title":"J Am Heart Association"},{"issue":"sup3","key":"4481_CR168","doi-asserted-by":"publisher","first-page":"S707","DOI":"10.1080\/21691401.2018.1508028","volume":"46","author":"S Mao","year":"2018","unstructured":"Mao S, Wang L, Chen P, et al. Nanoparticle-mediated delivery of Tanshinone IIA reduces adverse cardiac remodeling following myocardial infarctions in a mice model: role of NF-\u03baB pathway. Artif cells Nanomed Biotechnol. 2018;46(sup3):S707\u201316. https:\/\/doi.org\/10.1080\/21691401.2018.1508028.","journal-title":"Artif cells Nanomed Biotechnol"},{"issue":"9","key":"4481_CR169","doi-asserted-by":"publisher","first-page":"5407","DOI":"10.1073\/pnas.0931245100","volume":"100","author":"RA Smith","year":"2003","unstructured":"Smith RA, Porteous CM, Gane AM, et al. Delivery of bioactive molecules to mitochondria in vivo. Proc Natl Acad Sci USA. 2003;100(9):5407\u201312. https:\/\/doi.org\/10.1073\/pnas.0931245100.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4481_CR170","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.2147\/IJN.S165590","volume":"13","author":"S Zhang","year":"2018","unstructured":"Zhang S, Li J, Hu S, et al. Triphenylphosphonium and D-\u03b1-tocopheryl polyethylene glycol 1000 succinate-modified, tanshinone IIA-loaded lipid-polymeric nanocarriers for the targeted therapy of myocardial infarction. Int J Nanomed. 2018;13:4045\u201357. https:\/\/doi.org\/10.2147\/IJN.S165590. doi: 10.2147\/IJN.S165590.","journal-title":"Int J Nanomed"},{"key":"4481_CR171","doi-asserted-by":"publisher","first-page":"111693","DOI":"10.1016\/j.biopha.2021.111693","volume":"140","author":"T Zhu","year":"2021","unstructured":"Zhu T, Xie WJ, Wang L, et al. Notoginsenoside R1 activates the NAMPT-NAD+-SIRT1 cascade to promote postischemic angiogenesis by modulating Notch signaling. Biomed Pharmacother. 2021;140:111693. https:\/\/doi.org\/10.1016\/j.biopha.2021.111693.","journal-title":"Biomed Pharmacother"},{"key":"4481_CR172","doi-asserted-by":"publisher","first-page":"117004","DOI":"10.1016\/j.biopha.2024.117004","volume":"177","author":"Q Chen","year":"2024","unstructured":"Chen Q, Huang Z, Chen J, et al. Notoginsenoside R1 attenuates ischemic heart failure by modulating MDM2\/\u03b2 arrestin2-mediated \u03b22-adrenergic receptor ubiquitination. Biomed Pharmacother. 2024;177:117004. https:\/\/doi.org\/10.1016\/j.biopha.2024.117004.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"4481_CR173","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","volume":"119","author":"SD Prabhu","year":"2016","unstructured":"Prabhu SD, Frangogiannis NG. The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. Circul Res. 2016;119(1):91\u2013112. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.303577.","journal-title":"Circul Res"},{"key":"4481_CR174","doi-asserted-by":"publisher","first-page":"102384","DOI":"10.1016\/j.redox.2022.102384","volume":"54","author":"H Li","year":"2022","unstructured":"Li H, Zhu J, Xu YW, et al. Notoginsenoside R1-loaded mesoporous silica nanoparticles targeting the site of injury through inflammatory cells improves heart repair after myocardial infarction. Redox Biol. 2022;54:102384. https:\/\/doi.org\/10.1016\/j.redox.2022.102384.","journal-title":"Redox Biol"},{"issue":"3","key":"4481_CR175","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.1002\/jcb.27587","volume":"120","author":"Y Luan","year":"2019","unstructured":"Luan Y, Sun C, Wang J, et al. Baicalin attenuates myocardial ischemia-reperfusion injury through Akt\/NF-\u03baB pathway. J Cell Biochem. 2019;120(3):3212\u20139. https:\/\/doi.org\/10.1002\/jcb.27587.","journal-title":"J Cell Biochem"},{"issue":"1","key":"4481_CR176","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1080\/13880209.2020.1779318","volume":"58","author":"M Xu","year":"2020","unstructured":"Xu M, Li X, Song L. Baicalin regulates macrophages polarization and alleviates myocardial ischaemia\/reperfusion injury via inhibiting JAK\/STAT pathway. Pharm Biol. 2020;58(1):655\u201363. https:\/\/doi.org\/10.1080\/13880209.2020.1779318.","journal-title":"Pharm Biol"},{"issue":"1","key":"4481_CR177","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1080\/10717544.2021.1989086","volume":"28","author":"J Wang","year":"2021","unstructured":"Wang J, Zhang S, Di L. Acute myocardial infarction therapy: in vitro and in vivo evaluation of atrial natriuretic peptide and triphenylphosphonium dual ligands modified, baicalin-loaded nanoparticulate system. Drug Delivery. 2021;28(1):2198\u2013204. https:\/\/doi.org\/10.1080\/10717544.2021.1989086.","journal-title":"Drug Delivery"},{"issue":"1","key":"4481_CR178","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1186\/s12951-024-02796-8","volume":"22","author":"X Yu","year":"2024","unstructured":"Yu X, Wang J, Wang T, et al. Ellagic acid-enhanced biocompatibility and bioactivity in multilayer core-shell gold nanoparticles for ameliorating myocardial infarction injury. J Nanobiotechnol. 2024;22(1):554. https:\/\/doi.org\/10.1186\/s12951-024-02796-8.","journal-title":"J Nanobiotechnol"},{"key":"4481_CR179","doi-asserted-by":"publisher","first-page":"157587","DOI":"10.1016\/j.phymed.2025.157587","volume":"149","author":"H Li","year":"2025","unstructured":"Li H, Ruan J, Huang J, et al. Pomegranate peel and ellagic acid attenuate ulcerative colitis by targeting AKR1B1\/B3 to inhibit NLRP3. Phytomedicine. 2025;149:157587. https:\/\/doi.org\/10.1016\/j.phymed.2025.157587.","journal-title":"Phytomedicine"},{"issue":"19","key":"4481_CR180","doi-asserted-by":"publisher","first-page":"4781","DOI":"10.1039\/d4mh00642a","volume":"11","author":"Y Wang","year":"2024","unstructured":"Wang Y, Wu F, Li Y, et al. Ellagic acid-modified gold nanoparticles to combat multi-drug resistant bacterial infections in vitro and in vivo. Mater Horiz. 2024;11(19):4781\u201390. https:\/\/doi.org\/10.1039\/d4mh00642a.","journal-title":"Mater Horiz"},{"issue":"5","key":"4481_CR181","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1039\/c7fo00183e","volume":"8","author":"XF Guo","year":"2017","unstructured":"Guo XF, Li ZH, Cai H, et al. The effects of Lycium barbarum L. (L. barbarum) on cardiometabolic risk factors: a meta-analysis of randomized controlled trials. Food Funct. 2017;8(5):1741\u20138. https:\/\/doi.org\/10.1039\/c7fo00183e.","journal-title":"Food Funct"},{"issue":"1","key":"4481_CR182","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1186\/s12951-025-03615-4","volume":"23","author":"HH Zhou","year":"2025","unstructured":"Zhou HH, Zhou X, Pei J, et al. A fibrin gel-loaded Gouqi-derived nanovesicle (GqDNV) repairs the heart after myocardial infarction by inhibiting p38 MAPK\/NF-\u03baB p65 pathway. J Nanobiotechnol. 2025;23(1):535. https:\/\/doi.org\/10.1186\/s12951-025-03615-4.","journal-title":"J Nanobiotechnol"},{"key":"4481_CR183","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/j.biopha.2017.10.086","volume":"96","author":"J Qiu","year":"2017","unstructured":"Qiu J, Cai G, Liu X, et al. \u03b1v\u03b23 integrin receptor specific peptide modified, salvianolic acid B and panax notoginsenoside loaded nanomedicine for the combination therapy of acute myocardial ischemia. Biomed Pharmacother. 2017;96:1418\u201326. https:\/\/doi.org\/10.1016\/j.biopha.2017.10.086.","journal-title":"Biomed Pharmacother"},{"issue":"21","key":"4481_CR184","doi-asserted-by":"publisher","first-page":"7249","DOI":"10.1074\/jbc.RA119.011110","volume":"295","author":"S Miyamoto","year":"2020","unstructured":"Miyamoto S, Zhang G, Hall D, et al. Restoring mitochondrial superoxide levels with elamipretide (MTP-131) protects db\/db mice against progression of diabetic kidney disease. J Biol Chem. 2020;295(21):7249\u201360. https:\/\/doi.org\/10.1074\/jbc.RA119.011110.","journal-title":"J Biol Chem"},{"key":"4481_CR185","doi-asserted-by":"publisher","first-page":"122890","DOI":"10.1016\/j.biomaterials.2024.122890","volume":"314","author":"K Wang","year":"2025","unstructured":"Wang K, Sun Y, Zhu K, et al. Anti-pyroptosis biomimetic nanoplatform loading puerarin for myocardial infarction repair: From drug discovery to drug delivery. Biomaterials. 2025;314:122890. https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122890.","journal-title":"Biomaterials"},{"key":"4481_CR186","doi-asserted-by":"publisher","first-page":"109480","DOI":"10.1016\/j.biopha.2019.109480","volume":"120","author":"J Guo","year":"2019","unstructured":"Guo J, Xing X, Lv N, et al. Therapy for myocardial infarction: In vitro and in vivo evaluation of puerarin-prodrug and tanshinone co-loaded lipid nanoparticulate system. Biomed Pharmacother. 2019;120:109480. https:\/\/doi.org\/10.1016\/j.biopha.2019.109480.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"4481_CR187","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13020-023-00859-w","volume":"18","author":"Q Chen","year":"2023","unstructured":"Chen Q, Xu Q, Zhu H, et al. Salvianolic acid B promotes angiogenesis and inhibits cardiomyocyte apoptosis by regulating autophagy in myocardial ischemia. Chin Med. 2023;18(1):155. https:\/\/doi.org\/10.1186\/s13020-023-00859-w.","journal-title":"Chin Med"},{"key":"4481_CR188","doi-asserted-by":"publisher","first-page":"1452545","DOI":"10.3389\/fphar.2024.1452545","volume":"15","author":"Y Yang","year":"2024","unstructured":"Yang Y, Sun Z, Sun X, et al. Protective effect of salvianolic acid B against myocardial ischemia\/reperfusion injury: preclinical systematic evaluation and meta-analysis. Front Pharmacol. 2024;15:1452545. https:\/\/doi.org\/10.3389\/fphar.2024.1452545.","journal-title":"Front Pharmacol"},{"key":"4481_CR189","doi-asserted-by":"publisher","first-page":"157506","DOI":"10.1016\/j.phymed.2025.157506","volume":"149","author":"H Li","year":"2025","unstructured":"Li H, Shang Z, Shen A, et al. Panax notoginseng saponin mitigates glycolysis to regulate macrophage polarization and sphingolipid metabolism via hypoxia-inducible factor-1 to alleviate atherosclerosis. Phytomedicine. 2025;149:157506. https:\/\/doi.org\/10.1016\/j.phymed.2025.157506.","journal-title":"Phytomedicine"},{"issue":"1","key":"4481_CR190","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41420-025-02372-5","volume":"11","author":"B Du","year":"2025","unstructured":"Du B, Fu Q, Yang Q, et al. Different types of cell death and their interactions in myocardial ischemia-reperfusion injury. Cell death discovery. 2025;11(1):87. https:\/\/doi.org\/10.1038\/s41420-025-02372-5.","journal-title":"Cell death discovery"},{"issue":"5","key":"4481_CR191","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","volume":"18","author":"D Bertheloot","year":"2021","unstructured":"Bertheloot D, Latz E, Franklin BS. Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell Mol Immunol. 2021;18(5):1106\u201321. https:\/\/doi.org\/10.1038\/s41423-020-00630-3.","journal-title":"Cell Mol Immunol"},{"issue":"15","key":"4481_CR192","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1093\/cvr\/cvaf203","volume":"121","author":"Y Maejima","year":"2025","unstructured":"Maejima Y, Titus AS, Zablocki D, et al. Recent progress regarding the role of autophagy in cardiac disease. Cardiovasc Res. 2025;121(15):2299\u2013317. https:\/\/doi.org\/10.1093\/cvr\/cvaf203.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"4481_CR193","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41418-018-0212-6","volume":"26","author":"D Frank","year":"2019","unstructured":"Frank D, Vince JE. Pyroptosis versus necroptosis: similarities, differences, and crosstalk. Cell Death Differ. 2019;26(1):99\u2013114. https:\/\/doi.org\/10.1038\/s41418-018-0212-6.","journal-title":"Cell Death Differ"},{"issue":"1","key":"4481_CR194","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41392-025-02253-4","volume":"10","author":"X Xu","year":"2025","unstructured":"Xu X, Pang Y, Fan X. Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances. Signal Transduct Target Ther. 2025;10(1):190. https:\/\/doi.org\/10.1038\/s41392-025-02253-4.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"4481_CR195","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1002\/ptr.8118","volume":"38","author":"D Chen","year":"2024","unstructured":"Chen D, Duan H, Zou C, et al. 20(R)-ginsenoside Rg3 attenuates cerebral ischemia-reperfusion injury by mitigating mitochondrial oxidative stress via the Nrf2\/HO-1 signaling pathway. Phytother Res. 2024;38(3):1462\u201377. https:\/\/doi.org\/10.1002\/ptr.8118.","journal-title":"Phytother Res"},{"key":"4481_CR196","doi-asserted-by":"publisher","first-page":"110226","DOI":"10.1016\/j.neuropharm.2024.110226","volume":"263","author":"D Tao","year":"2025","unstructured":"Tao D, Li F, Zhang X, et al. 20(R)-ginsenoside Rg3 protects against focal cerebral ischemia\u2013reperfusion injury by suppressing autophagy via PI3K\/Akt\/mTOR signaling pathway. Neuropharmacology. 2025;263:110226. https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110226.","journal-title":"Neuropharmacology"},{"issue":"21","key":"4481_CR197","doi-asserted-by":"publisher","first-page":"4905","DOI":"10.3390\/molecules25214905","volume":"25","author":"M Nakhjavani","year":"2020","unstructured":"Nakhjavani M, Smith E, Townsend AR, et al. Anti-Angiogenic Properties of Ginsenoside Rg3. Molecules. 2020;25(21):4905. https:\/\/doi.org\/10.3390\/molecules25214905.","journal-title":"Molecules"},{"issue":"1","key":"4481_CR198","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12906-024-04492-4","volume":"24","author":"G Zhong","year":"2024","unstructured":"Zhong G, Chen J, Li Y, et al. Ginsenoside Rg3 attenuates myocardial ischemia\/reperfusion-induced ferroptosis via the keap1\/Nrf2\/GPX4 signaling pathway. BMC Complement Med Ther. 2024;24(1):247. https:\/\/doi.org\/10.1186\/s12906-024-04492-4.","journal-title":"BMC Complement Med Ther"},{"key":"4481_CR199","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jconrel.2019.11.032","volume":"317","author":"L Li","year":"2020","unstructured":"Li L, Wang Y, Guo R, et al. Ginsenoside Rg3-loaded, reactive oxygen species-responsive polymeric nanoparticles for alleviating myocardial ischemia-reperfusion injury. J Controlled Release. 2020;317:259\u201372. https:\/\/doi.org\/10.1016\/j.jconrel.2019.11.032.","journal-title":"J Controlled Release"},{"key":"4481_CR200","doi-asserted-by":"publisher","first-page":"628988","DOI":"10.3389\/fphar.2021.628988","volume":"12","author":"Z Fan","year":"2021","unstructured":"Fan Z, Cai L, Wang S, et al. Baicalin Prevents Myocardial Ischemia\/Reperfusion Injury Through Inhibiting ACSL4 Mediated Ferroptosis. Front Pharmacol. 2021;12:628988. https:\/\/doi.org\/10.3389\/fphar.2021.628988.","journal-title":"Front Pharmacol"},{"issue":"12","key":"4481_CR201","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1080\/09205063.2024.2358640","volume":"35","author":"C Chen","year":"2024","unstructured":"Chen C, Liu W, Gu X, et al. Baicalin-loaded Polydopamine modified ZIF-8 NPs inhibits myocardial ischemia\/reperfusion injury in rats. J biomaterials Sci Polym Ed. 2024;35(12):1863\u201378. https:\/\/doi.org\/10.1080\/09205063.2024.2358640.","journal-title":"J biomaterials Sci Polym Ed"},{"issue":"21","key":"4481_CR202","doi-asserted-by":"publisher","first-page":"e39031","DOI":"10.1016\/j.heliyon.2024.e39031","volume":"10","author":"D Xiong","year":"2024","unstructured":"Xiong D, Wang X, Wang H, et al. Quercetin inhibits cardiomyocyte apoptosis via Sirt3\/SOD2\/mitochondrial reactive oxygen species during myocardial ischemia-reperfusion injury. Heliyon. 2024;10(21):e39031. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e39031.","journal-title":"Heliyon"},{"key":"4481_CR203","doi-asserted-by":"publisher","first-page":"741","DOI":"10.2147\/IJN.S277377","volume":"16","author":"CJ Liu","year":"2021","unstructured":"Liu CJ, Yao L, Hu YM, et al. Effect of Quercetin-Loaded Mesoporous Silica Nanoparticles on Myocardial Ischemia-Reperfusion Injury in Rats and Its Mechanism. Int J Nanomed. 2021;16:741\u201352. https:\/\/doi.org\/10.2147\/IJN.S277377. doi: 10.2147\/IJN.S277377.","journal-title":"Int J Nanomed"},{"issue":"1","key":"4481_CR204","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1021\/nn5061404","volume":"9","author":"N Hardy","year":"2015","unstructured":"Hardy N, Viola HM, Johnstone VP, et al. Nanoparticle-mediated dual delivery of an antioxidant and a peptide against the L-Type Ca2\u2009+\u2009channel enables simultaneous reduction of cardiac ischemia-reperfusion injury. ACS Nano. 2015;9(1):279\u201389. https:\/\/doi.org\/10.1021\/nn5061404.","journal-title":"ACS Nano"},{"issue":"10","key":"4481_CR205","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1001\/jama.2020.13310","volume":"324","author":"JR Baman","year":"2020","unstructured":"Baman JR, Ahmad FS, Heart Failure. JAMA. 2020;324(10):1015. https:\/\/doi.org\/10.1001\/jama.2020.13310.","journal-title":"JAMA"},{"key":"4481_CR206","doi-asserted-by":"publisher","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895\u20131032. https:\/\/doi.org\/10.1161\/CIR.0000000000001063. https:\/\/doi.org\/10.1161\/CIR.0000000000001063. ACC\/AHA Joint Committee Members.","DOI":"10.1161\/CIR.0000000000001063"},{"key":"4481_CR207","doi-asserted-by":"publisher","unstructured":"McDonagh TA, Metra M, Adamo M, ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European heart journal. 2021;42(36):3599\u20133726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368.","DOI":"10.1093\/eurheartj\/ehab368"},{"issue":"6","key":"4481_CR208","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/cvr\/cvaa324","volume":"117","author":"NG Frangogiannis","year":"2021","unstructured":"Frangogiannis NG. Cardiac fibrosis. Cardiovascular Res. 2021;117(6):1450\u201388. https:\/\/doi.org\/10.1093\/cvr\/cvaa324.","journal-title":"Cardiovascular Res"},{"issue":"10","key":"4481_CR209","doi-asserted-by":"publisher","first-page":"e0311817","DOI":"10.1371\/journal.pone.0311817","volume":"19","author":"B Beikzadeh","year":"2024","unstructured":"Beikzadeh B, Khani M, Zarinehzadeh Y, et al. Preventive and treatment efficiency of dendrosomal nano-curcumin against ISO-induced cardiac fibrosis in mouse model. PLoS ONE. 2024;19(10):e0311817. https:\/\/doi.org\/10.1371\/journal.pone.0311817.","journal-title":"PLoS ONE"},{"key":"4481_CR210","doi-asserted-by":"publisher","first-page":"103223","DOI":"10.1016\/j.redox.2024.103223","volume":"74","author":"D Wang","year":"2024","unstructured":"Wang D, Yu X, Gao K, et al. Sweroside alleviates pressure overload-induced heart failure through targeting CaMK\u2161\u03b4 to inhibit ROS-mediated NF-\u03baB\/NLRP3 in cardiomyocytes. Redox Biol. 2024;74:103223. https:\/\/doi.org\/10.1016\/j.redox.2024.103223.","journal-title":"Redox Biol"},{"key":"4481_CR211","doi-asserted-by":"publisher","first-page":"154471","DOI":"10.1016\/j.phymed.2022.154471","volume":"107","author":"L Xu","year":"2022","unstructured":"Xu L, He D, Wu Y, et al. Tanshinone IIA inhibits cardiomyocyte apoptosis and rescues cardiac function during doxorubicin-induced cardiotoxicity by activating the DAXX\/MEK\/ERK1\/2 pathway. Phytomedicine. 2022;107:154471. https:\/\/doi.org\/10.1016\/j.phymed.2022.154471.","journal-title":"Phytomedicine"},{"key":"4481_CR212","doi-asserted-by":"publisher","first-page":"102610","DOI":"10.1016\/j.redox.2023.102610","volume":"60","author":"S Wan","year":"2023","unstructured":"Wan S, Cui Z, Wu L, et al. Ginsenoside Rd promotes omentin secretion in adipose through TBK1-AMPK to improve mitochondrial biogenesis via WNT5A\/Ca2+ pathways in heart failure. Redox Biol. 2023;60:102610. https:\/\/doi.org\/10.1016\/j.redox.2023.102610.","journal-title":"Redox Biol"},{"key":"4481_CR213","doi-asserted-by":"publisher","first-page":"108599","DOI":"10.1016\/j.biopha.2019.108599","volume":"112","author":"X Zhang","year":"2019","unstructured":"Zhang X, Wang Q, Wang X, et al. Tanshinone IIA protects against heart failure post-myocardial infarction via AMPKs\/mTOR-dependent autophagy pathway. Biomed Pharmacother. 2019;112:108599. https:\/\/doi.org\/10.1016\/j.biopha.2019.108599.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"4481_CR214","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3892\/mmr.2021.12043","volume":"23","author":"R Chen","year":"2021","unstructured":"Chen R, Chen W, Huang X, et al. Tanshinone IIA attenuates heart failure via inhibiting oxidative stress in myocardial infarction rats. Mol Med Rep. 2021;23(6):404. https:\/\/doi.org\/10.3892\/mmr.2021.12043.","journal-title":"Mol Med Rep"},{"issue":"3","key":"4481_CR215","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.3892\/mmr.2020.11272","volume":"22","author":"K Li","year":"2020","unstructured":"Li K, Wang X, Fan C, et al. Tanshinone IIA promotes cardiac differentiation and improves cell motility by modulating the Wnt\/\u03b2-catenin signaling pathway. Mol Med Rep. 2020;22(3):1839\u201346. https:\/\/doi.org\/10.3892\/mmr.2020.11272.","journal-title":"Mol Med Rep"},{"key":"4481_CR216","doi-asserted-by":"publisher","first-page":"125318","DOI":"10.1016\/j.ijpharm.2025.125318","volume":"672","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Wang J, Zhang Z, et al. A ROS-responsive TPP-modified tanshinone IIA micelle improves DOX-induced heart failure. Int J Pharm. 2025;672:125318. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125318.","journal-title":"Int J Pharm"},{"key":"4481_CR217","doi-asserted-by":"publisher","first-page":"123954","DOI":"10.1016\/j.biomaterials.2025.123954","volume":"329","author":"F Zhang","year":"2025","unstructured":"Zhang F, Zhao B, Lu K, et al. Bridging acute-chronic myocardial infarction treatment: Dual-regulating of ROS\/fibrosis via microenvironment-responsive release of NO and curcumin. Biomaterials. 2025;329:123954. https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123954.","journal-title":"Biomaterials"},{"issue":"2","key":"4481_CR218","doi-asserted-by":"publisher","first-page":"e2308477","DOI":"10.1002\/adma.202308477","volume":"36","author":"X Liu","year":"2024","unstructured":"Liu X, Chen B, Chen J, et al. A Cardiac-Targeted Nanozyme Interrupts the Inflammation-Free Radical Cycle in Myocardial Infarction. Adv Mater. 2024;36(2):e2308477. https:\/\/doi.org\/10.1002\/adma.202308477.","journal-title":"Adv Mater"},{"issue":"15","key":"4481_CR219","doi-asserted-by":"publisher","first-page":"e2404201","DOI":"10.1002\/adhm.202404201","volume":"14","author":"A Luo","year":"2025","unstructured":"Luo A, Tan J, Wang H, et al. Engineered Prussian Blue-Curcumin Nanozyme with RONS Scavenging Properties for Augmented Reversible Treatment of Cardiac Hypertrophy. Adv Healthc Mater. 2025;14(15):e2404201. https:\/\/doi.org\/10.1002\/adhm.202404201.","journal-title":"Adv Healthc Mater"},{"issue":"5","key":"4481_CR220","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1161\/CIRCULATIONAHA.124.070136","volume":"150","author":"EN Olson","year":"2024","unstructured":"Olson EN. Myocardial Regeneration: Feasible or Fantasy? Circulation. 2024;150(5):347\u20139. 10.1161. \/CIRCULATIONAHA.124.070136.","journal-title":"Circulation"},{"issue":"2","key":"4481_CR221","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.pharmthera.2004.10.003","volume":"105","author":"J Leor","year":"2005","unstructured":"Leor J, Amsalem Y, Cohen S. Cells, scaffolds, and molecules for myocardial tissue engineering. Pharmacol Ther. 2005;105(2):151\u201363. https:\/\/doi.org\/10.1016\/j.pharmthera.2004.10.003.","journal-title":"Pharmacol Ther"},{"issue":"2","key":"4481_CR222","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41569-023-00914-x","volume":"21","author":"M Weinberger","year":"2024","unstructured":"Weinberger M, Riley PR. Animal models to study cardiac regeneration. Nat reviews Cardiol. 2024;21(2):89\u2013105. 10.1038. \/s41569-023-00914-x.","journal-title":"Nat reviews Cardiol"},{"issue":"5601","key":"4481_CR223","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1126\/science.1077857","volume":"298","author":"KD Poss","year":"2002","unstructured":"Poss KD, Wilson LG, Keating MT. Heart regeneration in zebrafish. Sci (New York N Y). 2002;298(5601):2188\u201390. https:\/\/doi.org\/10.1126\/science.1077857.","journal-title":"Sci (New York N Y)"},{"issue":"3","key":"4481_CR224","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s44161-024-00450-y","volume":"3","author":"MS Ahmed","year":"2024","unstructured":"Ahmed MS, Nguyen NUN, Nakada Y, et al. Identification of FDA-approved drugs that induce heart regeneration in mammals. Nat Cardiovasc Res. 2024;3(3):372\u201388. https:\/\/doi.org\/10.1038\/s44161-024-00450-y.","journal-title":"Nat Cardiovasc Res"},{"issue":"7983","key":"4481_CR225","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41586-023-06585-5","volume":"622","author":"X Li","year":"2023","unstructured":"Li X, Wu F, G\u00fcnther S, et al. Inhibition of fatty acid oxidation enables heart regeneration in adult mice. Nature. 2023;622(7983):619\u201326. https:\/\/doi.org\/10.1038\/s41586-023-06585-5.","journal-title":"Nature"},{"issue":"24","key":"4481_CR226","doi-asserted-by":"publisher","first-page":"e2410590","DOI":"10.1002\/advs.202410590","volume":"12","author":"N Cheng","year":"2025","unstructured":"Cheng N, Luo Q, Yang Y, et al. Injectable pH Responsive Conductive Hydrogel for Intelligent Delivery of Metformin and Exosomes to Enhance Cardiac Repair after Myocardial Ischemia-Reperfusion Injury. Adv Sci (Weinh). 2025;12(24):e2410590. https:\/\/doi.org\/10.1002\/advs.202410590.","journal-title":"Adv Sci (Weinh)"},{"issue":"11","key":"4481_CR227","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1016\/j.biomaterials.2011.12.044","volume":"33","author":"Z Liu","year":"2012","unstructured":"Liu Z, Wang H, Wang Y, et al. The influence of chitosan hydrogel on stem cell engraftment, survival and homing in the ischemic myocardial microenvironment. Biomaterials. 2012;33(11):3093\u2013106. https:\/\/doi.org\/10.1016\/j.biomaterials.2011.12.044.","journal-title":"Biomaterials"},{"issue":"12","key":"4481_CR228","doi-asserted-by":"publisher","first-page":"e2400121","DOI":"10.1002\/smtd.202400121","volume":"8","author":"W Liu","year":"2024","unstructured":"Liu W, Long L, Wang Z, et al. A Whole-Course-Repair System Based on Stimulus-Responsive Multifunctional Hydrogels for Myocardial Tissue Regeneration. Small methods. 2024;8(12):e2400121. https:\/\/doi.org\/10.1002\/smtd.202400121.","journal-title":"Small methods"},{"issue":"11","key":"4481_CR229","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.2174\/1871530321666210104145231","volume":"21","author":"B Helli","year":"2021","unstructured":"Helli B, Gerami H, Kavianpour M, et al. Curcumin Nanomicelle Improves Lipid Profile, Stress Oxidative Factors and Inflammatory Markers in Patients Undergoing Coronary Elective Angioplasty; A Randomized Clinical Trial. Endocr Metab Immune Disord Drug Targets. 2021;21(11):2090\u20138. https:\/\/doi.org\/10.2174\/1871530321666210104145231.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"1","key":"4481_CR230","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1186\/s13063-024-08354-9","volume":"25","author":"M Soltani","year":"2024","unstructured":"Soltani M, Hosseinzadeh-Attar MJ, Rezaei M, et al. Effect of nano-curcumin supplementation on cardiometabolic risk factors, physical and psychological quality of life, and depression in patients with coronary slow flow phenomenon: a randomized double-blind clinical trial. Trials. 2024;25(1):515. https:\/\/doi.org\/10.1186\/s13063-024-08354-9.","journal-title":"Trials"},{"issue":"1","key":"4481_CR231","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/biof.1874","volume":"49","author":"M Dastani","year":"2023","unstructured":"Dastani M, Rahimi HR, Askari VR, et al. Three months of combination therapy with nano-curcumin reduces the inflammation and lipoprotein (a) in type 2 diabetic patients with mild to moderate coronary artery disease: Evidence of a randomized, double-blinded, placebo-controlled clinical trial. BioFactors. 2023;49(1):108\u201318. https:\/\/doi.org\/10.1002\/biof.1874.","journal-title":"BioFactors"},{"key":"4481_CR232","doi-asserted-by":"publisher","first-page":"1342832","DOI":"10.3389\/fcvm.2024.1342832","volume":"11","author":"LL Marinho","year":"2024","unstructured":"Marinho LL, Rached FH, Morikawa AT, et al. Safety and possible anti-inflammatory effect of paclitaxel associated with LDL-like nanoparticles (LDE) in patients with chronic coronary artery disease: a double-blind, placebo-controlled pilot study. Front Cardiovasc Med. 2024;11:1342832. https:\/\/doi.org\/10.3389\/fcvm.2024.1342832.","journal-title":"Front Cardiovasc Med"},{"key":"4481_CR233","doi-asserted-by":"publisher","first-page":"114083","DOI":"10.1016\/j.addr.2021.114083","volume":"181","author":"MA Younis","year":"2022","unstructured":"Younis MA, Tawfeek HM, Abdellatif AAH, et al. Clinical translation of nanomedicines: Challenges, opportunities, and keys. Adv Drug Deliv Rev. 2022;181:114083. https:\/\/doi.org\/10.1016\/j.addr.2021.114083.","journal-title":"Adv Drug Deliv Rev"},{"key":"4481_CR234","doi-asserted-by":"publisher","first-page":"111128","DOI":"10.1016\/j.colsurfb.2020.111128","volume":"193","author":"FG Baudou","year":"2020","unstructured":"Baudou FG, Fusco L, Giorgi E, et al. Physicochemical and biological characterization of nanovenoms, a new tool formed by silica nanoparticles and Crotalus durissus terrificus venom. Colloids Surf B Biointerfaces. 2020;193:111128. https:\/\/doi.org\/10.1016\/j.colsurfb.2020.111128.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"4481_CR235","doi-asserted-by":"publisher","first-page":"114356","DOI":"10.1016\/j.addr.2022.114356","volume":"186","author":"Q Xiao","year":"2022","unstructured":"Xiao Q, Zoulikha M, Qiu M, et al. The effects of protein corona on in vivo fate of nanocarriers. Adv Drug Deliv Rev. 2022;186:114356. https:\/\/doi.org\/10.1016\/j.addr.2022.114356.","journal-title":"Adv Drug Deliv Rev"},{"issue":"7","key":"4481_CR236","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.tips.2024.05.003","volume":"45","author":"G Caracciolo","year":"2024","unstructured":"Caracciolo G. Artificial protein coronas: directing nanoparticles to targets. Trends Pharmacol Sci. 2024;45(7):602\u201313. https:\/\/doi.org\/10.1016\/j.tips.2024.05.003.","journal-title":"Trends Pharmacol Sci"},{"key":"4481_CR237","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2024.07.060","volume":"374","author":"Y Huang","year":"2024","unstructured":"Huang Y, Ye D, Liu X, et al. Spiky tubular nanoparticles with low protein corona can realize efficient and non-destructive penetration through endothelial barrier. J Control Release. 2024;374:1\u201314. https:\/\/doi.org\/10.1016\/j.jconrel.2024.07.060.","journal-title":"J Control Release"},{"key":"4481_CR238","doi-asserted-by":"publisher","first-page":"114611","DOI":"10.1016\/j.ejpb.2024.114611","volume":"207","author":"D Kelle","year":"2025","unstructured":"Kelle D, Speth KR, Mart\u00ednez-Negro M, et al. Effect of protein corona on drug release behavior of PLGA nanoparticles. Eur J Pharm Biopharm. 2025;207:114611. https:\/\/doi.org\/10.1016\/j.ejpb.2024.114611.","journal-title":"Eur J Pharm Biopharm"},{"key":"4481_CR239","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.jconrel.2022.03.060","volume":"345","author":"M Song","year":"2022","unstructured":"Song M, Dong S, An X, et al. Erythrocyte-biomimetic nanosystems to improve antitumor effects of paclitaxel on epithelial cancers. J Control Release. 2022;345:744\u201354. https:\/\/doi.org\/10.1016\/j.jconrel.2022.03.060.","journal-title":"J Control Release"},{"issue":"16","key":"4481_CR240","doi-asserted-by":"publisher","first-page":"9738","DOI":"10.1039\/d4nr04999c","volume":"17","author":"X Du","year":"2025","unstructured":"Du X, Huang J, Zhao C, et al. Retrospective perspectives and future trends in nanomedicine treatment: from single membranes to hybrid membranes. Nanoscale. 2025;17(16):9738\u201363. https:\/\/doi.org\/10.1039\/d4nr04999c.","journal-title":"Nanoscale"},{"key":"4481_CR241","doi-asserted-by":"publisher","first-page":"rbad047","DOI":"10.1093\/rb\/rbad047","volume":"10","author":"H Zhang","year":"2023","unstructured":"Zhang H, Hu Z, Wang J, et al. Shear stress regulation of nanoparticle uptake in vascular endothelial cells. Regen Biomater. 2023;10:rbad047. https:\/\/doi.org\/10.1093\/rb\/rbad047.","journal-title":"Regen Biomater"},{"issue":"24","key":"4481_CR242","doi-asserted-by":"publisher","first-page":"e1906274","DOI":"10.1002\/adma.201906274","volume":"32","author":"YY Chen","year":"2020","unstructured":"Chen YY, Syed AM, MacMillan P, et al. Flow Rate Affects Nanoparticle Uptake into Endothelial Cells. Adv Mater. 2020;32(24):e1906274. https:\/\/doi.org\/10.1002\/adma.201906274.","journal-title":"Adv Mater"},{"key":"4481_CR243","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.bioactmat.2021.10.038","volume":"9","author":"X Qin","year":"2021","unstructured":"Qin X, Zhang K, Qiu J, et al. Uptake of oxidative stress-mediated extracellular vesicles by vascular endothelial cells under low magnitude shear stress. Bioact Mater. 2021;9:397\u2013410. https:\/\/doi.org\/10.1016\/j.bioactmat.2021.10.038.","journal-title":"Bioact Mater"},{"key":"4481_CR244","doi-asserted-by":"publisher","first-page":"105545","DOI":"10.1016\/j.cmpb.2020.105545","volume":"195","author":"S Jafarzadeh","year":"2020","unstructured":"Jafarzadeh S, Nasiri Sadr A, Kaffash E, et al. The Effect of Hematocrit and Nanoparticles Diameter on Hemodynamic Parameters and Drug Delivery in Abdominal Aortic Aneurysm with Consideration of Blood Pulsatile Flow. Comput Methods Programs Biomed. 2020;195:105545. https:\/\/doi.org\/10.1016\/j.cmpb.2020.105545.","journal-title":"Comput Methods Programs Biomed"},{"issue":"35","key":"4481_CR245","doi-asserted-by":"publisher","first-page":"e2202169","DOI":"10.1002\/adma.202202169","volume":"34","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Dalan R, Hu Z, et al. Reactive Oxygen Species Scavenging Nanomedicine for the Treatment of Ischemic Heart Disease. Adv Mater. 2022;34(35):e2202169. https:\/\/doi.org\/10.1002\/adma.202202169.","journal-title":"Adv Mater"},{"issue":"6","key":"4481_CR246","doi-asserted-by":"publisher","first-page":"e2104632","DOI":"10.1002\/smll.202104632","volume":"18","author":"X Li","year":"2022","unstructured":"Li X, Montague EC, Pollinzi A, et al. Design of Smart Size-, Surface-, and Shape-Switching Nanoparticles to Improve Therapeutic Efficacy. Small. 2022;18(6):e2104632. https:\/\/doi.org\/10.1002\/smll.202104632.","journal-title":"Small"},{"key":"4481_CR247","doi-asserted-by":"publisher","first-page":"103378","DOI":"10.1016\/j.cis.2024.103378","volume":"336","author":"F Heidari-Dalfard","year":"2025","unstructured":"Heidari-Dalfard F, Tavasoli S, Assadpour E, et al. Surface modification of particles\/nanoparticles to improve the stability of Pickering emulsions; a critical review. Adv Colloid Interface Sci. 2025;336:103378. https:\/\/doi.org\/10.1016\/j.cis.2024.103378.","journal-title":"Adv Colloid Interface Sci"},{"key":"4481_CR248","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.biomaterials.2018.09.015","volume":"185","author":"VV Shuvaev","year":"2018","unstructured":"Shuvaev VV, Khoshnejad M, Pulsipher KW, et al. Spatially controlled assembly of affinity ligand and enzyme cargo enables targeting ferritin nanocarriers to caveolae. Biomaterials. 2018;185:348\u201359. https:\/\/doi.org\/10.1016\/j.biomaterials.2018.09.015.","journal-title":"Biomaterials"},{"issue":"5","key":"4481_CR249","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1039\/c8tb02917b","volume":"7","author":"Z Qiao","year":"2019","unstructured":"Qiao Z, Yao Y, Song S, et al. Silver nanoparticles with pH induced surface charge switchable properties for antibacterial and antibiofilm applications. J Mater Chem B. 2019;7(5):830\u201340. https:\/\/doi.org\/10.1039\/c8tb02917b.","journal-title":"J Mater Chem B"},{"key":"4481_CR250","doi-asserted-by":"publisher","first-page":"103263","DOI":"10.1016\/j.cis.2024.103263","volume":"332","author":"TT Truong","year":"2024","unstructured":"Truong TT, Mondal S, Doan VHM, et al. Precision-engineered metal and metal-oxide nanoparticles for biomedical imaging and healthcare applications. Adv Colloid Interface Sci. 2024;332:103263. https:\/\/doi.org\/10.1016\/j.cis.2024.103263.","journal-title":"Adv Colloid Interface Sci"},{"issue":"11","key":"4481_CR251","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/nnano.2016.168","volume":"11","author":"S Zanganeh","year":"2016","unstructured":"Zanganeh S, Hutter G, Spitler R, et al. Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues. Nat Nanotechnol. 2016;11(11):986\u201394. https:\/\/doi.org\/10.1038\/nnano.2016.168.","journal-title":"Nat Nanotechnol"},{"issue":"17","key":"4481_CR252","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.1093\/cvr\/cvac032","volume":"118","author":"FME Segers","year":"2023","unstructured":"Segers FME, Ruder AV, Westra MM, et al. Magnetic resonance imaging contrast-enhancement with superparamagnetic iron oxide nanoparticles amplifies macrophage foam cell apoptosis in human and murine atherosclerosis. Cardiovasc Res. 2023;118(17):3346\u201359. https:\/\/doi.org\/10.1093\/cvr\/cvac032.","journal-title":"Cardiovasc Res"},{"key":"4481_CR253","doi-asserted-by":"publisher","first-page":"1569265","DOI":"10.3389\/fcvm.2025.1569265","volume":"12","author":"X Liu","year":"2025","unstructured":"Liu X, Deng H, Zhao Z, et al. ZnO nanoparticles induce acute arrhythmia and heart failure in mice by disturbing cardiac ion channels. Front Cardiovasc Med. 2025;12:1569265. https:\/\/doi.org\/10.3389\/fcvm.2025.1569265.","journal-title":"Front Cardiovasc Med"},{"key":"4481_CR254","doi-asserted-by":"publisher","first-page":"102739","DOI":"10.1016\/j.redox.2023.102739","volume":"63","author":"X Chang","year":"2023","unstructured":"Chang X, Niu S, Shang M, et al. ROS-Drp1-mediated mitochondria fission contributes to hippocampal HT22 cell apoptosis induced by silver nanoparticles. Redox Biol. 2023;63:102739. https:\/\/doi.org\/10.1016\/j.redox.2023.102739.","journal-title":"Redox Biol"},{"key":"4481_CR255","doi-asserted-by":"publisher","unstructured":"Yang Y, Fan S, Chen Q et al. Acute exposure to gold nanoparticles aggravates lipopolysaccharide-induced liver injury by amplifying apoptosis via ROS-mediated macrophage-hepatocyte crosstalk. J Nanobiotechnology. 2022;20(1):37. doi: 10.1186\/s12951-021-01203-w. Erratum in: J Nanobiotechnology. 2023;21(1):239. https:\/\/doi.org\/10.1186\/s12951-023-01972-6. https:\/\/doi.org\/10.1186\/s12951-021-01203-w.","DOI":"10.1186\/s12951-023-01972-6"},{"issue":"1","key":"4481_CR256","doi-asserted-by":"publisher","first-page":"ltac002","DOI":"10.1093\/immadv\/ltac002","volume":"2","author":"D Tatovic","year":"2022","unstructured":"Tatovic D, McAteer MA, Barry J, et al. Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes. Immunotherapy Adv. 2022;2(1):ltac002. https:\/\/doi.org\/10.1093\/immadv\/ltac002.","journal-title":"Immunotherapy Adv"},{"key":"4481_CR257","doi-asserted-by":"publisher","first-page":"105093","DOI":"10.1016\/j.yrtph.2021.105093","volume":"128","author":"A Mech","year":"2022","unstructured":"Mech A, Gottardo S, Amenta V, et al. Safe- and sustainable-by-design: The case of Smart Nanomaterials. A perspective based on a European workshop. Regul Toxicol Pharmacol. 2022;128:105093. https:\/\/doi.org\/10.1016\/j.yrtph.2021.105093.","journal-title":"Regul Toxicol Pharmacol"},{"key":"4481_CR258","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jconrel.2020.07.007","volume":"326","author":"M Germain","year":"2020","unstructured":"Germain M, Caputo F, Metcalfe S, et al. Delivering the power of nanomedicine to patients today. J Control Release. 2020;326:164\u201371. https:\/\/doi.org\/10.1016\/j.jconrel.2020.07.007.","journal-title":"J Control Release"},{"key":"4481_CR259","doi-asserted-by":"publisher","first-page":"105093","DOI":"10.1016\/j.yrtph.2021.105093","volume":"128","author":"A Mech","year":"2022","unstructured":"Mech A, Gottardo S, Amenta V, et al. Safe- and sustainable-by-design: The case of Smart Nanomaterials. A perspective based on a European workshop. Regul Toxicol Pharmacol. 2022;128:105093. https:\/\/doi.org\/10.1016\/j.yrtph.2021.105093.","journal-title":"Regul Toxicol Pharmacol"},{"key":"4481_CR260","doi-asserted-by":"publisher","first-page":"105360","DOI":"10.1016\/j.yrtph.2023.105360","volume":"139","author":"EAJ Bleeker","year":"2023","unstructured":"Bleeker EAJ, Swart E, Braakhuis H, et al. Towards harmonisation of testing of nanomaterials for EU regulatory requirements on chemical safety - A proposal for further actions. Regul Toxicol Pharmacol. 2023;139:105360. https:\/\/doi.org\/10.1016\/j.yrtph.2023.105360.","journal-title":"Regul Toxicol Pharmacol"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04481-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04481-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04481-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T01:20:33Z","timestamp":1783300833000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04481-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":260,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4481"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04481-4","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"19 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"621"}}